[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-7b_response": "Acrokeratosis paraneoplastica is a rare skin condition that is characterized by the development of thick, scaly, and discolored patches on the skin. These patches are most commonly found on the hands and feet, but can also appear on other areas of the body. The cause of this condition is unknown, but it has been linked to certain types of cancer. Synonyms for Acrokeratosis paraneoplastica include acrokeratotic paraneoplastic syndrome, acrokeratotic disorder of Blaschko, and Blaschko's disease.",
    "llama-7b_fact_raw": "1. Acrokeratosis paraneoplastica is characterized by thick, scaly, and discolored patches on the skin.\n2. These patches commonly appear on the hands and feet.\n3. The cause of Acrokeratosis paraneoplastica is unknown.\n4. Acrokeratosis paraneoplastica has been linked to certain types of cancer.\n5. Synonyms for Acrokeratosis paraneoplastica include acrokeratotic paraneoplastic syndrome, acrokeratotic disorder of Blaschko, and Blaschko's disease.",
    "llama-7b_fact": [
      "Acrokeratosis paraneoplastica is characterized by thick, scaly, and discolored patches on the skin.",
      "These patches commonly appear on the hands and feet.",
      "The cause of Acrokeratosis paraneoplastica is unknown.",
      "Acrokeratosis paraneoplastica has been linked to certain types of cancer.",
      "Synonyms for Acrokeratosis paraneoplastica include acrokeratotic paraneoplastic syndrome, acrokeratotic disorder of Blaschko, and Blaschko's disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Synonyms for Acrokeratosis paraneoplastica include Bazex syndrome, acrokeratosis neoplastica, and acrokeratosis paraneoplastica of Bazex.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-7b_response": "No, Weaver syndrome is not similar to Sotos. Weaver syndrome is a rare genetic disorder that is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features. Sotos syndrome is a rare genetic disorder that is characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features, but it is not the same as Weaver syndrome. Weaver syndrome is caused by mutations in the WFS1 gene, while Sotos syndrome is caused by mutations in the NSD1 gene.",
    "llama-7b_fact_raw": "1. Weaver syndrome is a rare genetic disorder characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features.\n2. Sotos syndrome is also a rare genetic disorder with similar characteristics to Weaver syndrome, including extreme overgrowth, intellectual disability, and distinctive facial features.\n3. Weaver syndrome is caused by mutations in the WFS1 gene.\n4. Sotos syndrome is caused by mutations in the NSD1 gene.",
    "llama-7b_fact": [
      "Weaver syndrome is a rare genetic disorder characterized by extreme overgrowth during childhood, intellectual disability, and distinctive facial features.",
      "Sotos syndrome is also a rare genetic disorder with similar characteristics to Weaver syndrome, including extreme overgrowth, intellectual disability, and distinctive facial features.",
      "Weaver syndrome is caused by mutations in the WFS1 gene.",
      "Sotos syndrome is caused by mutations in the NSD1 gene."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Weaver syndrome is caused by mutations in the EZH2 gene.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-7b_response": "The JASPAR database has been updated several times since its initial release in 1999. The most recent version, JASPAR 2019, was released in February 2019 and contains information on more than 4000 protein-coding transcripts from a variety of organisms. Previous versions of the database include JASPAR 2010 (released in 2010), JASPAR 2005 (released in 2005), and JASPAR 2002 (released in 2002).",
    "llama-7b_fact_raw": "1. The JASPAR database was initially released in 1999.\n2. JASPAR 2019, the most recent version, was released in February 2019.\n3. JASPAR 2019 contains information on more than 4000 protein-coding transcripts.\n4. Previous versions of the JASPAR database include JASPAR 2010, JASPAR 2005, and JASPAR 2002.\n5. JASPAR 2010 was released in 2010, JASPAR 2005 was released in 2005, and JASPAR 2002 was released in 2002.",
    "llama-7b_fact": [
      "The JASPAR database was initially released in 1999.",
      "JASPAR 2019, the most recent version, was released in February 2019.",
      "JASPAR 2019 contains information on more than 4000 protein-coding transcripts.",
      "Previous versions of the JASPAR database include JASPAR 2010, JASPAR 2005, and JASPAR 2002.",
      "JASPAR 2010 was released in 2010, JASPAR 2005 was released in 2005, and JASPAR 2002 was released in 2002."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The JASPAR database was initially released in 2004.\n2. FALSE [correction]: JASPAR 2020, not 2019, is the most recent version and was released in 2020.\n3. FALSE [correction]: JASPAR 2019 contains information on more than 1000 transcription factors, not protein-coding transcripts.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-7b_response": "The viral KP4 protein is a small, non-structural protein found in certain picornaviruses, including poliovirus. It is believed to play a role in the replication and assembly of the virus, as well as in the modulation of the host cell's gene expression. KP4 has also been shown to interact with cellular proteins, such as RNA polymerase II, which may help the virus to evade the host cell's immune system.",
    "llama-7b_fact_raw": "1. The viral KP4 protein is found in certain picornaviruses, including poliovirus.\n2. KP4 is believed to be involved in the replication and assembly of the virus.\n3. KP4 may play a role in modulating the host cell's gene expression.\n4. The KP4 protein has been shown to interact with cellular proteins, such as RNA polymerase II.",
    "llama-7b_fact": [
      "The viral KP4 protein is found in certain picornaviruses, including poliovirus.",
      "KP4 is believed to be involved in the replication and assembly of the virus.",
      "KP4 may play a role in modulating the host cell's gene expression.",
      "The KP4 protein has been shown to interact with cellular proteins, such as RNA polymerase II."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific context or scientific references, it is difficult to verify these statements about the KP4 protein.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-7b_response": "DITPA (3,5-diiodothyronine) is a thyroid hormone analog that is utilized in both experimental and clinical studies. It is a potent thyroid hormone agonist that has been studied for its potential to treat a variety of thyroid-related disorders, including hypothyroidism, hyperthyroidism, and thyroid cancer. DITPA is more potent than thyroid hormones such as triiodothyronine (T3) and thyroxine (T4) and has a longer half-life than these hormones, allowing for once-daily administration. DITPA has also been studied for its potential to improve cognitive function in patients with hypothyroidism.",
    "llama-7b_fact_raw": "1. DITPA is a thyroid hormone analog.\n2. DITPA is used in both experimental and clinical studies.\n3. DITPA has been studied for its potential to treat thyroid-related disorders such as hypothyroidism, hyperthyroidism, and thyroid cancer.\n4. DITPA is more potent than thyroid hormones like triiodothyronine (T3) and thyroxine (T4).\n5. DITPA has a longer half-life than T3 and T4, allowing for once-daily administration.",
    "llama-7b_fact": [
      "DITPA is a thyroid hormone analog.",
      "DITPA is used in both experimental and clinical studies.",
      "DITPA has been studied for its potential to treat thyroid-related disorders such as hypothyroidism, hyperthyroidism, and thyroid cancer.",
      "DITPA is more potent than thyroid hormones like triiodothyronine (T3) and thyroxine (T4).",
      "DITPA has a longer half-life than T3 and T4, allowing for once-daily administration."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DITPA is less potent than thyroid hormones like triiodothyronine (T3) and thyroxine (T4).\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-7b_response": "The COUGER tool is a software tool developed by Microsoft to help developers build and test applications on the Windows platform. It provides a graphical user interface that allows developers to quickly and easily create, debug, and deploy applications. It also provides a wide range of debugging and testing features, such as breakpoints, code stepping, and memory dumps.",
    "llama-7b_fact_raw": "1. The COUGER tool is a software tool developed by Microsoft.\n2. The COUGER tool is designed to assist developers in building and testing applications on the Windows platform.\n3. It provides a graphical user interface for developers to create, debug, and deploy applications.\n4. The COUGER tool includes debugging features like breakpoints, code stepping, and memory dumps.",
    "llama-7b_fact": [
      "The COUGER tool is a software tool developed by Microsoft.",
      "The COUGER tool is designed to assist developers in building and testing applications on the Windows platform.",
      "It provides a graphical user interface for developers to create, debug, and deploy applications.",
      "The COUGER tool includes debugging features like breakpoints, code stepping, and memory dumps."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-7b_response": "Yes, there are drugs available to treat Tick-borne Encephalitis. These include antiviral medications such as oseltamivir and zanamivir, as well as immunoglobulin therapy which can help reduce the severity of symptoms.",
    "llama-7b_fact_raw": "1. Tick-borne Encephalitis can be treated with antiviral medications.\n2. Oseltamivir and zanamivir are drugs used to treat Tick-borne Encephalitis.\n3. Immunoglobulin therapy is used to help reduce the severity of symptoms in Tick-borne Encephalitis.",
    "llama-7b_fact": [
      "Tick-borne Encephalitis can be treated with antiviral medications.",
      "Oseltamivir and zanamivir are drugs used to treat Tick-borne Encephalitis.",
      "Immunoglobulin therapy is used to help reduce the severity of symptoms in Tick-borne Encephalitis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There are no specific antiviral medications for Tick-borne Encephalitis; treatment is supportive and focuses on relieving symptoms.\n2. FALSE [correction]: Oseltamivir and zanamivir are antiviral medications used to treat influenza, not Tick-borne Encephalitis.\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-7b_response": "The Genome Browser database for DNA shape annotations is available through the UCSC Genome Browser.",
    "llama-7b_fact_raw": "1. The UCSC Genome Browser provides a database for DNA shape annotations.",
    "llama-7b_fact": [
      "The UCSC Genome Browser provides a database for DNA shape annotations."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-7b_response": "Syndromes associated with mutations in the EZH2 gene include Beckwith-Wiedemann Syndrome, Silver-Russell Syndrome, Proteus Syndrome, and Juvenile Polyposis Syndrome.",
    "llama-7b_fact_raw": "1. Beckwith-Wiedemann Syndrome is associated with mutations in the EZH2 gene.\n2. Silver-Russell Syndrome is associated with mutations in the EZH2 gene.\n3. Proteus Syndrome is associated with mutations in the EZH2 gene.\n4. Juvenile Polyposis Syndrome is associated with mutations in the EZH2 gene.",
    "llama-7b_fact": [
      "Beckwith-Wiedemann Syndrome is associated with mutations in the EZH2 gene.",
      "Silver-Russell Syndrome is associated with mutations in the EZH2 gene.",
      "Proteus Syndrome is associated with mutations in the EZH2 gene.",
      "Juvenile Polyposis Syndrome is associated with mutations in the EZH2 gene."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Beckwith-Wiedemann Syndrome is associated with changes on chromosome 11p15, not mutations in the EZH2 gene.\n2. FALSE [correction]: Silver-Russell Syndrome is associated with changes on chromosome 7 and 11, not mutations in the EZH2 gene.\n3. FALSE [correction]: Proteus Syndrome is associated with a mutation in the AKT1 gene, not the EZH2 gene.\n4. FALSE [correction]: Juvenile Polyposis Syndrome is associated with mutations in the SMAD4 or BMPR1A gene, not the EZH2 gene.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-7b_response": "The human proteins that are subject to a dimer-to-tetramer transition are the transcription factors Oct4, Sox2, Klf4, and c-Myc. These proteins form dimers in the cytoplasm and undergo a dimer-to-tetramer transition upon entry into the nucleus, where they bind to DNA and regulate gene expression.",
    "llama-7b_fact_raw": "1. Oct4 is a human protein that undergoes a dimer-to-tetramer transition.\n2. Sox2 is a human protein that undergoes a dimer-to-tetramer transition.\n3. Klf4 is a human protein that undergoes a dimer-to-tetramer transition.\n4. c-Myc is a human protein that undergoes a dimer-to-tetramer transition.\n5. These proteins form dimers in the cytoplasm and transition to tetramers upon entry into the nucleus.",
    "llama-7b_fact": [
      "Oct4 is a human protein that undergoes a dimer-to-tetramer transition.",
      "Sox2 is a human protein that undergoes a dimer-to-tetramer transition.",
      "Klf4 is a human protein that undergoes a dimer-to-tetramer transition.",
      "c-Myc is a human protein that undergoes a dimer-to-tetramer transition.",
      "These proteins form dimers in the cytoplasm and transition to tetramers upon entry into the nucleus."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about the structural transitions and functions of the mentioned proteins, it is not possible to determine the accuracy of these statements. Additional context or scientific evidence would be needed to verify these claims.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-7b_response": "The protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is Bcl-2.",
    "llama-7b_fact_raw": "1. Bcl-2 is a protein that interacts with phospholamban (PLN).\n2. Bcl-2 is an anti-apoptotic protein.",
    "llama-7b_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-7b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. A systematic review and meta-analysis of randomized controlled trials found that vitamin D supplementation significantly reduced the risk of falls in older people by 22-37%. Additionally, a 2019 Cochrane review found that vitamin D supplementation can reduce the risk of falls in older people by 19%.",
    "llama-7b_fact_raw": "1. Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.\n2. A systematic review and meta-analysis found that vitamin D supplementation reduced the risk of falls by 22-37% in older people.\n3. A 2019 Cochrane review found that vitamin D supplementation can reduce the risk of falls by 19% in older people.",
    "llama-7b_fact": [
      "Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.",
      "A systematic review and meta-analysis found that vitamin D supplementation reduced the risk of falls by 22-37% in older people.",
      "A 2019 Cochrane review found that vitamin D supplementation can reduce the risk of falls by 19% in older people."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-7b_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Studies have shown that miR-155 is upregulated in Th17 cells and that Jarid2 is a direct target of miR-155. This suggests that the expression of Jarid2 is negatively regulated by miR-155 in Th17 cells.",
    "llama-7b_fact_raw": "1. There is an association between Jarid2 and miR-155 in Th17 cells.\n2. Studies have shown that miR-155 is upregulated in Th17 cells.\n3. Jarid2 is a direct target of miR-155.\n4. The expression of Jarid2 is negatively regulated by miR-155 in Th17 cells.",
    "llama-7b_fact": [
      "There is an association between Jarid2 and miR-155 in Th17 cells.",
      "Studies have shown that miR-155 is upregulated in Th17 cells.",
      "Jarid2 is a direct target of miR-155.",
      "The expression of Jarid2 is negatively regulated by miR-155 in Th17 cells."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-7b_response": "The human hoxD cluster contains 11 genes.",
    "llama-7b_fact_raw": "1. The human hoxD cluster contains 11 genes.",
    "llama-7b_fact": [
      "The human hoxD cluster contains 11 genes."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The human HOXD cluster contains 9 genes.",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-7b_response": "The phosphorylation consensus motifs for Casein Kinase 1 (CK1) are:\n\n1. S/T-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-x-",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-7b_response": "The ASPH gene encodes three different proteins/isoforms in humans: aspartate beta-hydroxylase, aspartate beta-semialdehyde dehydrogenase, and aspartate beta-semialdehyde transaminase.",
    "llama-7b_fact_raw": "1. The ASPH gene in humans encodes for the protein/isoform aspartate beta-hydroxylase.\n2. The ASPH gene in humans encodes for the protein/isoform aspartate beta-semialdehyde dehydrogenase.\n3. The ASPH gene in humans encodes for the protein/isoform aspartate beta-semialdehyde transaminase.",
    "llama-7b_fact": [
      "The ASPH gene in humans encodes for the protein/isoform aspartate beta-hydroxylase.",
      "The ASPH gene in humans encodes for the protein/isoform aspartate beta-semialdehyde dehydrogenase.",
      "The ASPH gene in humans encodes for the protein/isoform aspartate beta-semialdehyde transaminase."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The ASPH gene in humans does not encode for aspartate beta-semialdehyde dehydrogenase; this function is encoded by the ALDH4A1 gene.\n3. FALSE [correction]: The ASPH gene in humans does not encode for aspartate beta-semialdehyde transaminase; this function is encoded by the GOT1 or GOT2 genes.",
    "llama-7b_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-7b_response": "Empagliflozin was approved by the FDA in August 2014 for the treatment of adults with type 2 diabetes.",
    "llama-7b_fact_raw": "1. Empagliflozin was approved by the FDA in August 2014.\n2. Empagliflozin is used for the treatment of adults with type 2 diabetes.",
    "llama-7b_fact": [
      "Empagliflozin was approved by the FDA in August 2014.",
      "Empagliflozin is used for the treatment of adults with type 2 diabetes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-7b_response": "Loss of the protein Lon1 in the plant Arabidopsis results in a decrease in the lifespan of the plant. This is because Lon1 is a protein that is involved in the regulation of the cell cycle and its absence leads to an increase in the number of cells in the plant, which can cause premature aging and death.",
    "llama-7b_fact_raw": "1. Loss of the protein Lon1 in Arabidopsis leads to a decrease in the plant's lifespan.\n2. Lon1 is a protein involved in the regulation of the cell cycle in Arabidopsis.\n3. The absence of Lon1 results in an increase in the number of cells in Arabidopsis.\n4. An increase in cell number due to the absence of Lon1 can cause premature aging and death in Arabidopsis.",
    "llama-7b_fact": [
      "Loss of the protein Lon1 in Arabidopsis leads to a decrease in the plant's lifespan.",
      "Lon1 is a protein involved in the regulation of the cell cycle in Arabidopsis.",
      "The absence of Lon1 results in an increase in the number of cells in Arabidopsis.",
      "An increase in cell number due to the absence of Lon1 can cause premature aging and death in Arabidopsis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-7b_response": "Yes, a linker histone exists in the yeast genome. It is encoded by the Htz1 gene and is involved in the formation of nucleosomes, which are the basic building blocks of chromatin.",
    "llama-7b_fact_raw": "1. A linker histone exists in the yeast genome.\n2. The Htz1 gene encodes the linker histone in yeast.\n3. The linker histone is involved in the formation of nucleosomes.\n4. Nucleosomes are the basic building blocks of chromatin.",
    "llama-7b_fact": [
      "A linker histone exists in the yeast genome.",
      "The Htz1 gene encodes the linker histone in yeast.",
      "The linker histone is involved in the formation of nucleosomes.",
      "Nucleosomes are the basic building blocks of chromatin."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Yeast does not have linker histones; instead, they have non-histone proteins that fulfill similar roles.\n2. FALSE [correction]: The Htz1 gene in yeast encodes the histone variant H2A.Z, not the linker histone.\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-7b_response": "Yes, there is evidence that tomato juice can lower cholesterol levels. A study published in the American Journal of Clinical Nutrition found that drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce total cholesterol and low-density lipoprotein (LDL) cholesterol levels. The study also found that the juice had no effect on HDL cholesterol levels.",
    "llama-7b_fact_raw": "1. A study published in the American Journal of Clinical Nutrition found that tomato juice can lower cholesterol levels.\n2. Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce total cholesterol levels.\n3. Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce low-density lipoprotein (LDL) cholesterol levels.\n4. The study found that tomato juice had no effect on high-density lipoprotein (HDL) cholesterol levels.",
    "llama-7b_fact": [
      "A study published in the American Journal of Clinical Nutrition found that tomato juice can lower cholesterol levels.",
      "Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce total cholesterol levels.",
      "Drinking 240 milliliters (8 ounces) of tomato juice per day can significantly reduce low-density lipoprotein (LDL) cholesterol levels.",
      "The study found that tomato juice had no effect on high-density lipoprotein (HDL) cholesterol levels."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\n[Explanation]: Without access to the specific study from the American Journal of Clinical Nutrition and the details of its findings, it is not possible to verify the accuracy of these statements.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-7b_response": "Hsp70 and Hsp110 are molecular chaperones that help to fold and stabilize proteins. They are also involved in the regulation of mRNA stability. Hsp70 binds to the 5' untranslated region of mRNAs and helps to prevent their degradation, while Hsp110 binds to the 3' untranslated region and promotes the stability of mRNAs. Both Hsp70 and Hsp110 are important for the proper expression of genes and the maintenance of cell homeostasis.",
    "llama-7b_fact_raw": "1. Hsp70 and Hsp110 are molecular chaperones that aid in protein folding and stabilization.\n2. Hsp70 binds to the 5' untranslated region of mRNAs.\n3. Hsp110 binds to the 3' untranslated region of mRNAs.\n4. Both Hsp70 and Hsp110 are involved in the regulation of mRNA stability.\n5. Hsp70 and Hsp110 contribute to proper gene expression and maintenance of cell homeostasis.",
    "llama-7b_fact": [
      "Hsp70 and Hsp110 are molecular chaperones that aid in protein folding and stabilization.",
      "Hsp70 binds to the 5' untranslated region of mRNAs.",
      "Hsp110 binds to the 3' untranslated region of mRNAs.",
      "Both Hsp70 and Hsp110 are involved in the regulation of mRNA stability.",
      "Hsp70 and Hsp110 contribute to proper gene expression and maintenance of cell homeostasis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hsp70 typically binds to nascent polypeptide chains, not the 5' untranslated region of mRNAs.\n3. FALSE [correction]: There is no widely accepted evidence that Hsp110 binds to the 3' untranslated region of mRNAs.\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-7b_response": "Two deiodinases are present in skeletal muscle: DIO1 and DIO2. DIO1 is responsible for the conversion of T4 to T3, while DIO2 is responsible for the conversion of T3 to rT3.",
    "llama-7b_fact_raw": "1. DIO1 and DIO2 are deiodinases present in skeletal muscle.\n2. DIO1 is responsible for the conversion of T4 to T3.\n3. DIO2 is responsible for the conversion of T3 to rT3.",
    "llama-7b_fact": [
      "DIO1 and DIO2 are deiodinases present in skeletal muscle.",
      "DIO1 is responsible for the conversion of T4 to T3.",
      "DIO2 is responsible for the conversion of T3 to rT3."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DIO2 is responsible for the conversion of T4 to T3, not T3 to rT3.",
    "llama-7b_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-7b_response": "Caspase-1, -2, -3, -4, -5, -6, -7, -8, -9, and -11.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-7b_response": "Yes, there is a known link between the aurora B kinase and the polycomb protein ring1B. The aurora B kinase phosphorylates the ring1B protein, which is a component of the polycomb repressive complex 1 (PRC1). This phosphorylation leads to the dissociation of PRC1 from chromatin, resulting in the activation of target genes.",
    "llama-7b_fact_raw": "1. Aurora B kinase phosphorylates the ring1B protein.\n2. Ring1B protein is a component of the polycomb repressive complex 1 (PRC1).\n3. Phosphorylation of ring1B leads to the dissociation of PRC1 from chromatin.\n4. The dissociation of PRC1 results in the activation of target genes.",
    "llama-7b_fact": [
      "Aurora B kinase phosphorylates the ring1B protein.",
      "Ring1B protein is a component of the polycomb repressive complex 1 (PRC1).",
      "Phosphorylation of ring1B leads to the dissociation of PRC1 from chromatin.",
      "The dissociation of PRC1 results in the activation of target genes."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are known as dinucleotides, which are composed of two nucleotides. The most common dinucleotides at the donor splice site are AG and GT, while the most common dinucleotides at the acceptor splice site are GU and CT. These motifs are important for the recognition of the splice sites by the U1 and U2 small nuclear ribonucleoproteins (snRNPs).",
    "llama-7b_fact_raw": "1. The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are dinucleotides.\n2. Dinucleotides are composed of two nucleotides.\n3. AG and GT are the most common dinucleotides at the donor splice site.\n4. GU and CT are the most common dinucleotides at the acceptor splice site.\n5. The recognition of splice sites by U1 and U2 small nuclear ribonucleoproteins (snRNPs) involves these motifs.",
    "llama-7b_fact": [
      "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are dinucleotides.",
      "Dinucleotides are composed of two nucleotides.",
      "AG and GT are the most common dinucleotides at the donor splice site.",
      "GU and CT are the most common dinucleotides at the acceptor splice site.",
      "The recognition of splice sites by U1 and U2 small nuclear ribonucleoproteins (snRNPs) involves these motifs."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The most common dinucleotides at the acceptor splice site are AG and CT.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-7b_response": "The acetylation of S6K1 is catalyzed by the p300 histone acetyltransferase, which is activated by the phosphorylation of S6K1 by the protein kinase Akt.",
    "llama-7b_fact_raw": "1. The acetylation of S6K1 is catalyzed by the p300 histone acetyltransferase.\n2. The acetylation of S6K1 occurs after the phosphorylation of S6K1.\n3. The protein kinase Akt is responsible for the phosphorylation of S6K1.",
    "llama-7b_fact": [
      "The acetylation of S6K1 is catalyzed by the p300 histone acetyltransferase.",
      "The acetylation of S6K1 occurs after the phosphorylation of S6K1.",
      "The protein kinase Akt is responsible for the phosphorylation of S6K1."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-7b_response": "The cause of episodic ataxia type 6 is a mutation in the CACNA1A gene. This gene provides instructions for making a protein called the alpha-1A subunit of the voltage-gated calcium channel. The alpha-1A subunit is one of the proteins that make up the calcium channel, a protein complex that regulates the flow of calcium ions into the cell. The mutation that causes episodic ataxia type 6 results in a change in the amino acid sequence of the alpha-1A subunit, which disrupts the function of the calcium channel and leads to the symptoms of the disorder.",
    "llama-7b_fact_raw": "1. Episodic ataxia type 6 is caused by a mutation in the CACNA1A gene.\n2. The CACNA1A gene provides instructions for making the alpha-1A subunit of the voltage-gated calcium channel.\n3. The alpha-1A subunit is part of the protein complex that makes up the calcium channel.\n4. The mutation in episodic ataxia type 6 changes the amino acid sequence of the alpha-1A subunit.\n5. The disrupted function of the calcium channel due to the mutation leads to the symptoms of episodic ataxia type 6.",
    "llama-7b_fact": [
      "Episodic ataxia type 6 is caused by a mutation in the CACNA1A gene.",
      "The CACNA1A gene provides instructions for making the alpha-1A subunit of the voltage-gated calcium channel.",
      "The alpha-1A subunit is part of the protein complex that makes up the calcium channel.",
      "The mutation in episodic ataxia type 6 changes the amino acid sequence of the alpha-1A subunit.",
      "The disrupted function of the calcium channel due to the mutation leads to the symptoms of episodic ataxia type 6."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-7b_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that catalyze the transfer of a methyl group from one molecule to another. They are involved in a variety of biochemical reactions, including the methylation of DNA, RNA, and proteins. Chromomethylases have been found in the genomes of many animals, including humans.",
    "llama-7b_fact_raw": "1. Chromomethylases are present in animal genomes.\n2. Chromomethylases catalyze the transfer of a methyl group between molecules.\n3. They are involved in the methylation of DNA, RNA, and proteins.\n4. Chromomethylases have been found in the genomes of humans.",
    "llama-7b_fact": [
      "Chromomethylases are present in animal genomes.",
      "Chromomethylases catalyze the transfer of a methyl group between molecules.",
      "They are involved in the methylation of DNA, RNA, and proteins.",
      "Chromomethylases have been found in the genomes of humans."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Chromomethylases are present in plant genomes, not animal genomes.\n2. TRUE\n3. FALSE [correction]: Chromomethylases are specifically involved in the methylation of DNA, not RNA and proteins.\n4. FALSE [correction]: Chromomethylases have not been found in the genomes of humans, as they are specific to plants.",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-7b_response": "The following packages are available in R/Bioconductor for transcription factor binding site (TFBS) analysis: \n\n1. Arabidopsis Transcription Factor Binding Site Database (ATFBSD) \n2. ChIPPeakAnnotator \n3. ChIPseeker \n4. DNase-seq PeakAnnotator \n5. FAIRE-seq PeakAnnotator \n6. Genomic Regions Enrichment of Transcription Factor (GREAT) \n7. Homer \n8. MotifSampler \n9. PFAM Transcription Factor Binding Sites \n10. Transfac \n11. Transcription Factor Binding Site Search Utility (TFBSeq) \n12. Transcription Factor Binding Site Search Utility (TFBSeq) 2.0 \n13. Transcription Factor Binding Site Search Utility (TFBSeq) 3.0 \n14. Transcription Factor Binding Site Search Utility (TFBSeq) 4.0 \n15. Transcription Factor Binding Site Search Utility (TFBSeq) 5.0 \n16. Transcription Factor Binding Site Search Utility (TFBSeq) 6.0 \n17. Transcription Factor Binding Site Search Utility (TFBSeq) 7.0 \n18. Transcription Factor Binding Site Search Utility (TFBSeq) 8.0 \n19. Transcription Factor Binding Site Search Utility (TFBSeq) 9.0 \n20. Transcription Factor Binding Site Search Utility (TFBSeq) 10.0 \n21. Transcription Factor Binding Site Search Utility (TFBSeq) 11.0 \n22. Transcription Factor Binding Site Search Utility (TFBSeq) 12.0 \n23. Transcription Factor Binding Site Search Utility (TFBSeq) 13.0 \n24. Transcription Factor Binding Site Search Utility (TFBSeq) 14.0 \n25. Transcription Factor Binding Site Search Utility (TFBSeq) 15.0 \n26. Transcription Factor Binding Site Search Utility (TF",
    "llama-7b_fact_raw": "1. Arabidopsis Transcription Factor Binding Site Database (ATFBSD) is a package available in R/Bioconductor for TFBS analysis.\n2. ChIPPeakAnnotator is a package available in R/Bioconductor for TFBS analysis.\n3. ChIPseeker is a package available in R/Bioconductor for TFBS analysis.\n4. DNase-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis.\n5. FAIRE-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis.",
    "llama-7b_fact": [
      "Arabidopsis Transcription Factor Binding Site Database (ATFBSD) is a package available in R/Bioconductor for TFBS analysis.",
      "ChIPPeakAnnotator is a package available in R/Bioconductor for TFBS analysis.",
      "ChIPseeker is a package available in R/Bioconductor for TFBS analysis.",
      "DNase-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis.",
      "FAIRE-seq PeakAnnotator is a package available in R/Bioconductor for TFBS analysis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Arabidopsis Transcription Factor Binding Site Database (ATFBSD) is not a package, it is a database.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: DNase-seq PeakAnnotator is not available in R/Bioconductor for TFBS analysis.\n5. FALSE [correction]: FAIRE-seq PeakAnnotator is not available in R/Bioconductor for TFBS analysis.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-7b_response": "Clinical trials for the prevention of sarcopenia include the Sarcopenia Prevention Evaluation (SARPREV) trial, the Sarcopenia Prevention Evaluation (SARPREV-2) trial, the Sarcopenia Prevention Evaluation (SARPREV-3) trial, the Sarcopenia Prevention Evaluation (SARPREV-4) trial, the Sarcopenia Prevention Evaluation (SARPREV-5) trial, the Sarcopenia Prevention Evaluation (SARPREV-6) trial, the Sarcopenia Prevention Evaluation (SARPREV-7) trial, the Sarcopenia Prevention Evaluation (SARPREV-8) trial, the Sarcopenia Prevention Evaluation (SARPREV-9) trial, the Sarcopenia Prevention Evaluation (SARPREV-10) trial, the Sarcopenia Prevention Evaluation (SARPREV-11) trial, the Sarcopenia Prevention Evaluation (SARPREV-12) trial, the Sarcopenia Prevention Evaluation (SARPREV-13) trial, the Sarcopenia Prevention Evaluation (SARPREV-14) trial, the Sarcopenia Prevention Evaluation (SARPREV-15) trial, the Sarcopenia Prevention Evaluation (SARPREV-16) trial, the Sarcopenia Prevention Evaluation (SARPREV-17) trial, the Sarcopenia Prevention Evaluation (SARPREV-18) trial, the Sarcopenia Prevention Evaluation (SARPREV-19) trial, the Sarcopenia Prevention Evaluation (SARPREV-20) trial, the Sarcopenia Prevention Evaluation (SARPREV-21) trial, the Sarcopenia Prevention Evaluation (SARPREV-22) trial, the Sarcopenia Prevention Evaluation (SARPREV-23) trial, the Sarcopenia Prevention Evaluation (SARPREV-24) trial, the Sarcopen",
    "llama-7b_fact_raw": "1. The Sarcopenia Prevention Evaluation (SARPREV) trial is a clinical trial for the prevention of sarcopenia.\n2. There are at least 24 Sarcopenia Prevention Evaluation (SARPREV) trials, ranging from SARPREV-1 to SARPREV-24.",
    "llama-7b_fact": [
      "The Sarcopenia Prevention Evaluation (SARPREV) trial is a clinical trial for the prevention of sarcopenia.",
      "There are at least 24 Sarcopenia Prevention Evaluation (SARPREV) trials, ranging from SARPREV-1 to SARPREV-24."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-7b_response": "The Database of Molecular Recognition Features in Membrane Proteins (DMRM) is a comprehensive database that provides information about molecular recognition features in membrane proteins. It contains information about the types of features, their locations, and the amino acid residues involved in the recognition process. The database also provides a platform for researchers to share their data and insights.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. It is cleared primarily by the cytochrome P450 2C9 (CYP2C9) enzyme, which is primarily located in the liver and kidneys. The metabolites of rivaroxaban are mainly excreted in the urine. Therefore, kidney function is an important factor in the elimination of rivaroxaban from the body.",
    "llama-7b_fact_raw": "1. Rivaroxaban is metabolized in the kidneys.\n2. The cytochrome P450 2C9 (CYP2C9) enzyme is involved in the clearance of rivaroxaban.\n3. CYP2C9 enzyme is primarily located in the liver and kidneys.\n4. Metabolites of rivaroxaban are mainly excreted in the urine.\n5. Kidney function is important for the elimination of rivaroxaban from the body.",
    "llama-7b_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "The cytochrome P450 2C9 (CYP2C9) enzyme is involved in the clearance of rivaroxaban.",
      "CYP2C9 enzyme is primarily located in the liver and kidneys.",
      "Metabolites of rivaroxaban are mainly excreted in the urine.",
      "Kidney function is important for the elimination of rivaroxaban from the body."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Rivaroxaban is primarily metabolized in the liver.\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-7b_response": "TRalpha2 is a nuclear receptor that plays an important role in the development and function of the heart. Studies have shown that TRalpha2 is involved in the regulation of genes that are important for cardiac growth and development, including genes that code for proteins involved in cardiac muscle contraction, electrical conduction, and heart rhythm regulation. Additionally, TRalpha2 has been shown to regulate genes involved in the development of cardiac hypertrophy and heart failure.",
    "llama-7b_fact_raw": "1. TRalpha2 is a nuclear receptor involved in heart development and function.\n2. TRalpha2 regulates genes important for cardiac growth and development.\n3. TRalpha2 influences the regulation of genes coding for proteins involved in cardiac muscle contraction.\n4. TRalpha2 plays a role in the regulation of genes related to electrical conduction and heart rhythm regulation.\n5. TRalpha2 has been shown to regulate genes involved in the development of cardiac hypertrophy and heart failure.",
    "llama-7b_fact": [
      "TRalpha2 is a nuclear receptor involved in heart development and function.",
      "TRalpha2 regulates genes important for cardiac growth and development.",
      "TRalpha2 influences the regulation of genes coding for proteins involved in cardiac muscle contraction.",
      "TRalpha2 plays a role in the regulation of genes related to electrical conduction and heart rhythm regulation.",
      "TRalpha2 has been shown to regulate genes involved in the development of cardiac hypertrophy and heart failure."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Note: Without specific scientific context or reference to literature, it is not possible to determine the accuracy of these statements about TRalpha2.]",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-7b_response": "There are several biomedical question answering systems available, including PubMedQA, MEDQA, BioASQ, and Biocreative III. PubMedQA is a question answering system for biomedical literature, MEDQA is a question answering system for medical textbooks, BioASQ is a question answering system for genomics data, and Biocreative III is a question answering system for biomedical research papers.",
    "llama-7b_fact_raw": "1. PubMedQA is a question answering system for biomedical literature.\n2. MEDQA is a question answering system for medical textbooks.\n3. BioASQ is a question answering system for genomics data.\n4. Biocreative III is a question answering system for biomedical research papers.",
    "llama-7b_fact": [
      "PubMedQA is a question answering system for biomedical literature.",
      "MEDQA is a question answering system for medical textbooks.",
      "BioASQ is a question answering system for genomics data.",
      "Biocreative III is a question answering system for biomedical research papers."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Biocreative III is a challenge evaluation for text mining and information extraction in the biomedical domain, not a question answering system.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-7b_response": "The trancription factor that activates the betalain pathway is the Betaine-Homocysteine S-Methyltransferase 2 (BHMT2) protein. BHMT2 is a key regulator of the betalain pathway, which is responsible for the synthesis of the pigments that give beets and other plants their red and yellow colors. BHMT2 binds to the promoter region of the genes that code for the enzymes involved in the betalain pathway and activates their transcription, thereby initiating the pathway.",
    "llama-7b_fact_raw": "1. The Betaine-Homocysteine S-Methyltransferase 2 (BHMT2) protein activates the betalain pathway.\n2. BHMT2 is a key regulator of the betalain pathway.\n3. The betalain pathway is responsible for the synthesis of pigments that give beets and other plants their red and yellow colors.\n4. BHMT2 binds to the promoter region of genes that code for enzymes involved in the betalain pathway.\n5. BHMT2 activates the transcription of genes involved in the betalain pathway.",
    "llama-7b_fact": [
      "The Betaine-Homocysteine S-Methyltransferase 2 (BHMT2) protein activates the betalain pathway.",
      "BHMT2 is a key regulator of the betalain pathway.",
      "The betalain pathway is responsible for the synthesis of pigments that give beets and other plants their red and yellow colors.",
      "BHMT2 binds to the promoter region of genes that code for enzymes involved in the betalain pathway.",
      "BHMT2 activates the transcription of genes involved in the betalain pathway."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-7b_response": "The preferred technologies for the enrichment of phosphorylated peptides are titanium dioxide (TiO2), immobilized metal affinity chromatography (IMAC), and metal-chelate affinity chromatography (MCA).",
    "llama-7b_fact_raw": "1. Titanium dioxide (TiO2) is a preferred technology for the enrichment of phosphorylated peptides.\n2. Immobilized metal affinity chromatography (IMAC) is a preferred technology for the enrichment of phosphorylated peptides.\n3. Metal-chelate affinity chromatography (MCA) is a preferred technology for the enrichment of phosphorylated peptides.",
    "llama-7b_fact": [
      "Titanium dioxide (TiO2) is a preferred technology for the enrichment of phosphorylated peptides.",
      "Immobilized metal affinity chromatography (IMAC) is a preferred technology for the enrichment of phosphorylated peptides.",
      "Metal-chelate affinity chromatography (MCA) is a preferred technology for the enrichment of phosphorylated peptides."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-7b_response": "The disorder rated by the Palmini classification is Obsessive Compulsive Disorder (OCD).",
    "llama-7b_fact_raw": "1. The Palmini classification is used to rate Obsessive Compulsive Disorder (OCD).",
    "llama-7b_fact": [
      "The Palmini classification is used to rate Obsessive Compulsive Disorder (OCD)."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is used to rate Obsessive Compulsive Disorder (OCD).",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-7b_response": "Yes, viruses are involved in the etiology of human subacute thyroiditis. Several studies have suggested that viruses, such as the rubella virus and the human papillomavirus, can cause subacute thyroiditis. These viruses can cause inflammation and destruction of the thyroid gland, leading to the clinical features of subacute thyroiditis.",
    "llama-7b_fact_raw": "1. Viruses are involved in the etiology of human subacute thyroiditis.\n2. The rubella virus can cause subacute thyroiditis.\n3. The human papillomavirus can cause subacute thyroiditis.\n4. Inflammation and destruction of the thyroid gland can lead to clinical features of subacute thyroiditis.",
    "llama-7b_fact": [
      "Viruses are involved in the etiology of human subacute thyroiditis.",
      "The rubella virus can cause subacute thyroiditis.",
      "The human papillomavirus can cause subacute thyroiditis.",
      "Inflammation and destruction of the thyroid gland can lead to clinical features of subacute thyroiditis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The mumps virus, not the rubella virus, is associated with subacute thyroiditis.\n3. FALSE [correction]: There is no known association between human papillomavirus and subacute thyroiditis.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-7b_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy. STAT3 is a transcription factor that plays an important role in the regulation of cell growth and metabolism. It has been reported that STAT3 binds to the promoter region of EIF2AK2 and inhibits its expression, leading to the suppression of autophagy.",
    "llama-7b_fact_raw": "1. STAT3 is involved in EIF2AK2-dependent suppression of autophagy.\n2. STAT3 is a transcription factor that regulates cell growth and metabolism.\n3. STAT3 binds to the promoter region of EIF2AK2.\n4. Binding of STAT3 to EIF2AK2's promoter region inhibits EIF2AK2's expression.\n5. Inhibition of EIF2AK2's expression leads to suppression of autophagy.",
    "llama-7b_fact": [
      "STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
      "STAT3 is a transcription factor that regulates cell growth and metabolism.",
      "STAT3 binds to the promoter region of EIF2AK2.",
      "Binding of STAT3 to EIF2AK2's promoter region inhibits EIF2AK2's expression.",
      "Inhibition of EIF2AK2's expression leads to suppression of autophagy."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-7b_response": "The Theatre software tool is used for genomic analysis and is designed to facilitate the analysis of large-scale genomic data sets. It provides a graphical user interface (GUI) that allows users to quickly and easily visualize, navigate, and analyze their genomic data. It also provides a range of analysis tools, such as alignment, annotation, and comparison tools, which can be used to gain insights into the structure and function of genomes.",
    "llama-7b_fact_raw": "1. The Theatre software tool is designed for genomic analysis.\n2. Theatre software facilitates the analysis of large-scale genomic data sets.\n3. The software provides a graphical user interface for visualizing, navigating, and analyzing genomic data.\n4. Theatre offers analysis tools including alignment, annotation, and comparison tools.\n5. The tools within Theatre software are used to gain insights into the structure and function of genomes.",
    "llama-7b_fact": [
      "The Theatre software tool is designed for genomic analysis.",
      "Theatre software facilitates the analysis of large-scale genomic data sets.",
      "The software provides a graphical user interface for visualizing, navigating, and analyzing genomic data.",
      "Theatre offers analysis tools including alignment, annotation, and comparison tools.",
      "The tools within Theatre software are used to gain insights into the structure and function of genomes."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Without additional context or information about the \"Theatre\" software tool, it is not possible to determine the accuracy of the statements.]",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-7b_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(m*n), where m and n are the lengths of the two sequences.",
    "llama-7b_fact_raw": "1. The Smith-Waterman algorithm is used for the alignment of two sequences.\n2. The execution time (complexity) of the Smith-Waterman algorithm is O(m*n).\n3. The variables m and n represent the lengths of the two sequences being aligned.",
    "llama-7b_fact": [
      "The Smith-Waterman algorithm is used for the alignment of two sequences.",
      "The execution time (complexity) of the Smith-Waterman algorithm is O(m*n).",
      "The variables m and n represent the lengths of the two sequences being aligned."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-7b_response": "FLVCR1 is a member of the SLC family.",
    "llama-7b_fact_raw": "1. FLVCR1 is a member of the SLC family.",
    "llama-7b_fact": [
      "FLVCR1 is a member of the SLC family."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: FLVCR1 is not a member of the SLC family; it is a member of the major facilitator superfamily (MFS).",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-7b_response": "GATA-1 interacting partners that have been discovered with the help of the biotinylation tagging approach include transcription factors such as GATA-2, GATA-3, GATA-4, and GATA-5; transcriptional co-activators such as p300, CBP, and PCAF; and transcriptional co-repressors such as SMRT and N-CoR. Additionally, GATA-1 has been shown to interact with several proteins involved in cell growth and proliferation, including c-Myc, cyclin D1, and CDK4.",
    "llama-7b_fact_raw": "1. GATA-1 interacts with other transcription factors such as GATA-2, GATA-3, GATA-4, and GATA-5.\n2. GATA-1 interacts with transcriptional co-activators including p300, CBP, and PCAF.\n3. GATA-1 interacts with transcriptional co-repressors such as SMRT and N-CoR.\n4. GATA-1 has been shown to interact with proteins involved in cell growth and proliferation like c-Myc.\n5. GATA-1 has been shown to interact with cyclin D1 and CDK4.",
    "llama-7b_fact": [
      "GATA-1 interacts with other transcription factors such as GATA-2, GATA-3, GATA-4, and GATA-5.",
      "GATA-1 interacts with transcriptional co-activators including p300, CBP, and PCAF.",
      "GATA-1 interacts with transcriptional co-repressors such as SMRT and N-CoR.",
      "GATA-1 has been shown to interact with proteins involved in cell growth and proliferation like c-Myc.",
      "GATA-1 has been shown to interact with cyclin D1 and CDK4."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-7b_response": "The interaction of TAF10 with the GATA1 transcription factor leads to the activation of GATA1-dependent genes, which are involved in the development and function of the cardiovascular system. This interaction also plays a role in the differentiation of embryonic stem cells and the formation of the heart, blood vessels, and other organs.",
    "llama-7b_fact_raw": "1. The interaction of TAF10 with GATA1 transcription factor activates GATA1-dependent genes.\n2. GATA1-dependent genes are involved in the development and function of the cardiovascular system.\n3. The interaction between TAF10 and GATA1 plays a role in the differentiation of embryonic stem cells.\n4. The interaction of TAF10 with GATA1 is involved in the formation of the heart, blood vessels, and other organs.",
    "llama-7b_fact": [
      "The interaction of TAF10 with GATA1 transcription factor activates GATA1-dependent genes.",
      "GATA1-dependent genes are involved in the development and function of the cardiovascular system.",
      "The interaction between TAF10 and GATA1 plays a role in the differentiation of embryonic stem cells.",
      "The interaction of TAF10 with GATA1 is involved in the formation of the heart, blood vessels, and other organs."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-7b_response": "Yes, there are several Decision support systems for chronic pain management. These systems are designed to help healthcare providers and patients make informed decisions about the best treatment options for chronic pain. For example, the Pain Management Decision Support System (PM-DSS) is a web-based tool that provides evidence-based recommendations for the management of chronic pain. The system takes into account the patient's medical history, current medications, and other factors to generate personalized treatment plans.",
    "llama-7b_fact_raw": "1. Decision support systems exist to aid in chronic pain management.\n2. These systems assist healthcare providers and patients in making informed decisions on treatment options.\n3. The Pain Management Decision Support System (PM-DSS) is an example of such a system.\n4. PM-DSS is web-based and provides evidence-based recommendations for chronic pain management.\n5. PM-DSS considers patient's medical history, current medications, and other factors to create personalized treatment plans.",
    "llama-7b_fact": [
      "Decision support systems exist to aid in chronic pain management.",
      "These systems assist healthcare providers and patients in making informed decisions on treatment options.",
      "The Pain Management Decision Support System (PM-DSS) is an example of such a system.",
      "PM-DSS is web-based and provides evidence-based recommendations for chronic pain management.",
      "PM-DSS considers patient's medical history, current medications, and other factors to create personalized treatment plans."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-7b_response": "Angiogenin is a secreted protein that localizes to the extracellular space.",
    "llama-7b_fact_raw": "1. Angiogenin is a secreted protein.\n2. Angiogenin localizes to the extracellular space.",
    "llama-7b_fact": [
      "Angiogenin is a secreted protein.",
      "Angiogenin localizes to the extracellular space."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-7b_response": "Ranolazine is a novel anti-angina drug that inhibits the voltage-gated potassium channel Kv1.5. This leads to an increase in the concentration of extracellular potassium, which in turn inhibits the activity of protein kinase A (PKA) and protein kinase C (PKC). As a result, ranolazine reduces the activity of protein kinase-dependent signaling pathways, such as the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways, which are important in the regulation of cardiac hypertrophy and remodeling. By inhibiting these kinase signaling pathways, ranolazine reduces myocardial ischemia and angina pectoris.",
    "llama-7b_fact_raw": "1. Ranolazine inhibits the voltage-gated potassium channel Kv1.5.\n2. Inhibition of Kv1.5 by ranolazine increases the concentration of extracellular potassium.\n3. Ranolazine inhibits the activity of protein kinase A (PKA) and protein kinase C (PKC).\n4. Ranolazine reduces the activity of protein kinase-dependent signaling pathways, including MAPK and PI3K pathways.\n5. By inhibiting kinase signaling pathways, ranolazine reduces myocardial ischemia and angina pectoris.",
    "llama-7b_fact": [
      "Ranolazine inhibits the voltage-gated potassium channel Kv1.5.",
      "Inhibition of Kv1.5 by ranolazine increases the concentration of extracellular potassium.",
      "Ranolazine inhibits the activity of protein kinase A (PKA) and protein kinase C (PKC).",
      "Ranolazine reduces the activity of protein kinase-dependent signaling pathways, including MAPK and PI3K pathways.",
      "By inhibiting kinase signaling pathways, ranolazine reduces myocardial ischemia and angina pectoris."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Ranolazine inhibits the late sodium current (INa) in the heart, not the voltage-gated potassium channel Kv1.5.\n2. FALSE [correction]: Inhibition of Kv1.5 would decrease the outward flow of potassium, potentially increasing intracellular potassium concentration, but ranolazine does not inhibit Kv1.5.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-7b_response": "Yes, the regulation of Vsr endonuclease is independent of the growth phase of bacteria. This means that the enzyme's activity is not affected by the stage of bacterial growth. Vsr endonuclease is an RNA-specific endonuclease that plays a role in the bacterial stress response. It is activated in response to the presence of double-stranded RNA and is involved in the degradation of mRNAs that contain viral-like sequences.",
    "llama-7b_fact_raw": "1. The regulation of Vsr endonuclease is independent of the bacterial growth phase.\n2. Vsr endonuclease is an RNA-specific endonuclease.\n3. Vsr endonuclease is involved in the bacterial stress response.\n4. Activation of Vsr endonuclease occurs in response to the presence of double-stranded RNA.\n5. Vsr endonuclease is involved in the degradation of mRNAs containing viral-like sequences.",
    "llama-7b_fact": [
      "The regulation of Vsr endonuclease is independent of the bacterial growth phase.",
      "Vsr endonuclease is an RNA-specific endonuclease.",
      "Vsr endonuclease is involved in the bacterial stress response.",
      "Activation of Vsr endonuclease occurs in response to the presence of double-stranded RNA.",
      "Vsr endonuclease is involved in the degradation of mRNAs containing viral-like sequences."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Vsr endonuclease is a DNA-specific endonuclease.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-7b_response": "Computational tools for the prediction of beta-barrel transmembrane proteins include the beta-barrel prediction algorithm of TMHMM, the beta-barrel assembly line (BARL) algorithm, and the beta-barrel topology predictor (BTP). TMHMM is a Hidden Markov Model (HMM) based method that uses a training dataset of beta-barrel proteins to predict the beta-barrel topology of a given protein. BARL is an algorithm that uses a combination of HMMs and threading to predict the beta-barrel topology of a given protein. BTP is a web server that uses a combination of HMMs and neural networks to predict the beta-barrel topology of a given protein.",
    "llama-7b_fact_raw": "1. TMHMM is a computational tool that uses a Hidden Markov Model based method for predicting beta-barrel transmembrane proteins.\n2. TMHMM's prediction method relies on a training dataset of beta-barrel proteins.\n3. The beta-barrel assembly line (BARL) algorithm combines Hidden Markov Models and threading for predicting beta-barrel topology.\n4. The beta-barrel topology predictor (BTP) is a web server that employs both Hidden Markov Models and neural networks for its predictions.",
    "llama-7b_fact": [
      "TMHMM is a computational tool that uses a Hidden Markov Model based method for predicting beta-barrel transmembrane proteins.",
      "TMHMM's prediction method relies on a training dataset of beta-barrel proteins.",
      "The beta-barrel assembly line (BARL) algorithm combines Hidden Markov Models and threading for predicting beta-barrel topology.",
      "The beta-barrel topology predictor (BTP) is a web server that employs both Hidden Markov Models and neural networks for its predictions."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: TMHMM is a computational tool that uses a Hidden Markov Model based method for predicting alpha-helix transmembrane proteins.\n2. FALSE [correction]: TMHMM's prediction method relies on a training dataset of alpha-helical transmembrane proteins.\n3. TRUE\n4. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-7b_response": "Galassi classification is used to classify epileptic seizures.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-7b_response": "Common features of Shapiro syndrome include short stature, intellectual disability, distinctive facial features such as a broad forehead, epicanthal folds, and a short, upturned nose, and speech and language delays. People with Shapiro syndrome may also have hearing loss, heart defects, and kidney abnormalities.",
    "llama-7b_fact_raw": "1. Shapiro syndrome is characterized by short stature.\n2. Intellectual disability is a common feature of Shapiro syndrome.\n3. Distinctive facial features associated with Shapiro syndrome include a broad forehead, epicanthal folds, and a short, upturned nose.\n4. Speech and language delays are common in individuals with Shapiro syndrome.\n5. Shapiro syndrome may be associated with hearing loss, heart defects, and kidney abnormalities.",
    "llama-7b_fact": [
      "Shapiro syndrome is characterized by short stature.",
      "Intellectual disability is a common feature of Shapiro syndrome.",
      "Distinctive facial features associated with Shapiro syndrome include a broad forehead, epicanthal folds, and a short, upturned nose.",
      "Speech and language delays are common in individuals with Shapiro syndrome.",
      "Shapiro syndrome may be associated with hearing loss, heart defects, and kidney abnormalities."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is characterized by episodes of spontaneous hypothermia, sweating, and agenesis of the corpus callosum; short stature is not a defining characteristic.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: Shapiro syndrome does not typically involve hearing loss, heart defects, or kidney abnormalities; these are not commonly associated features of the syndrome.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-7b_response": "BRAG1-related cancer is linked to mutations in the BRAG1 gene. These mutations can cause changes in the protein produced by the BRAG1 gene, which can lead to uncontrolled cell growth and the development of cancer.",
    "llama-7b_fact_raw": "1. BRAG1-related cancer is associated with mutations in the BRAG1 gene.\n2. Mutations in the BRAG1 gene can cause changes in the protein it produces.\n3. Changes in the BRAG1 protein can lead to uncontrolled cell growth.\n4. Uncontrolled cell growth due to BRAG1 protein changes can result in the development of cancer.",
    "llama-7b_fact": [
      "BRAG1-related cancer is associated with mutations in the BRAG1 gene.",
      "Mutations in the BRAG1 gene can cause changes in the protein it produces.",
      "Changes in the BRAG1 protein can lead to uncontrolled cell growth.",
      "Uncontrolled cell growth due to BRAG1 protein changes can result in the development of cancer."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-7b_response": "The protein that is the main inhibitor of protein phosphatase 1 (PP1) is PP1 catalytic subunit inhibitor 1 (PPI1). PPI1 is a protein that binds to and inhibits the activity of the PP1 catalytic subunit, preventing it from dephosphorylating other proteins.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-7b_response": "Adaptive mutagenesis in Bacillus subtilis, also known as stationary-phase mutagenesis, is a process by which the bacteria undergoes a series of genetic changes that allow it to better survive in its environment. This process is initiated when the bacteria enters a stationary phase, which is a dormant state where the bacteria is not actively growing. During this phase, the bacteria undergoes a series of genetic changes, such as point mutations, deletions, and insertions, which allow it to better survive in its environment. These changes are then passed on to the next generation, allowing the bacteria to better adapt to its environment.",
    "llama-7b_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis is also known as stationary-phase mutagenesis.\n2. Stationary-phase mutagenesis is initiated when the bacteria enters a stationary phase.\n3. The stationary phase is a dormant state where the bacteria is not actively growing.\n4. During stationary-phase mutagenesis, the bacteria undergoes genetic changes such as point mutations, deletions, and insertions.\n5. The genetic changes from stationary-phase mutagenesis are passed on to the next generation of bacteria.",
    "llama-7b_fact": [
      "Adaptive mutagenesis in Bacillus subtilis is also known as stationary-phase mutagenesis.",
      "Stationary-phase mutagenesis is initiated when the bacteria enters a stationary phase.",
      "The stationary phase is a dormant state where the bacteria is not actively growing.",
      "During stationary-phase mutagenesis, the bacteria undergoes genetic changes such as point mutations, deletions, and insertions.",
      "The genetic changes from stationary-phase mutagenesis are passed on to the next generation of bacteria."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-7b_response": "Erucism is caused by a deficiency of alpha-linolenic acid (an omega-3 fatty acid) in the diet. This deficiency can be due to a diet that is low in plant sources of omega-3 fatty acids, such as flaxseed, chia seed, and walnut, or to a diet that is low in overall fat. It can also be caused by certain medical conditions, such as cystic fibrosis, that affect fat absorption.",
    "llama-7b_fact_raw": "1. Erucism is caused by a deficiency of alpha-linolenic acid, an omega-3 fatty acid.\n2. A diet low in plant sources of omega-3 fatty acids can lead to erucism.\n3. Flaxseed, chia seed, and walnut are plant sources of omega-3 fatty acids.\n4. A diet low in overall fat can cause erucism.\n5. Medical conditions that affect fat absorption, such as cystic fibrosis, can cause erucism.",
    "llama-7b_fact": [
      "Erucism is caused by a deficiency of alpha-linolenic acid, an omega-3 fatty acid.",
      "A diet low in plant sources of omega-3 fatty acids can lead to erucism.",
      "Flaxseed, chia seed, and walnut are plant sources of omega-3 fatty acids.",
      "A diet low in overall fat can cause erucism.",
      "Medical conditions that affect fat absorption, such as cystic fibrosis, can cause erucism."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Erucism is a condition caused by contact with irritating caterpillar hairs, not by a dietary deficiency.\n2. FALSE [correction]: A diet low in plant sources of omega-3 fatty acids does not lead to erucism, but may lead to other health issues.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-7b_response": "Hydrochlorothiazide is indicated for the treatment of hypertension, fluid retention, and swelling due to congestive heart failure, and for the prevention of kidney stones. It can also be used to treat mild to moderate edema in patients with heart, liver, or kidney disease.",
    "llama-7b_fact_raw": "1. Hydrochlorothiazide is used to treat hypertension.\n2. Hydrochlorothiazide is used to treat fluid retention and swelling due to congestive heart failure.\n3. Hydrochlorothiazide can help prevent kidney stones.\n4. Hydrochlorothiazide can be used to treat mild to moderate edema in patients with heart, liver, or kidney disease.",
    "llama-7b_fact": [
      "Hydrochlorothiazide is used to treat hypertension.",
      "Hydrochlorothiazide is used to treat fluid retention and swelling due to congestive heart failure.",
      "Hydrochlorothiazide can help prevent kidney stones.",
      "Hydrochlorothiazide can be used to treat mild to moderate edema in patients with heart, liver, or kidney disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-7b_response": "Yes, silicon has been used in the treatment of incontinence. It is a common material used in the construction of urinary catheters, which are inserted into the urethra to help manage urinary incontinence. Silicon is also used in the construction of sling procedures, which are used to support the urethra and bladder to help reduce incontinence.",
    "llama-7b_fact_raw": "1. Silicon has been used in the treatment of incontinence.\n2. Silicon is a common material used in the construction of urinary catheters.\n3. Urinary catheters are inserted into the urethra to help manage urinary incontinence.\n4. Silicon is used in the construction of sling procedures.\n5. Sling procedures are used to support the urethra and bladder to help reduce incontinence.",
    "llama-7b_fact": [
      "Silicon has been used in the treatment of incontinence.",
      "Silicon is a common material used in the construction of urinary catheters.",
      "Urinary catheters are inserted into the urethra to help manage urinary incontinence.",
      "Silicon is used in the construction of sling procedures.",
      "Sling procedures are used to support the urethra and bladder to help reduce incontinence."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Silicone, not silicon, has been used in the treatment of incontinence.\n2. FALSE [correction]: Silicone, not silicon, is a common material used in the construction of urinary catheters.\n3. TRUE\n4. FALSE [correction]: Silicone, not silicon, is used in the construction of sling procedures.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-7b_response": "The association between the moon cycle and rupture risk of intracranial aneurysms is controversial. Some studies have suggested that the risk of rupture is higher during the full moon, while others have found no correlation between the moon cycle and rupture risk. It is believed that the lunar cycle may affect the pressure in the brain, which could affect the risk of rupture. Further research is needed to better understand the relationship between the moon cycle and rupture risk of intracranial aneurysms.",
    "llama-7b_fact_raw": "1. Some studies suggest a higher risk of intracranial aneurysm rupture during the full moon.\n2. Other studies have found no correlation between the moon cycle and rupture risk of intracranial aneurysms.\n3. It is hypothesized that the lunar cycle may affect pressure in the brain.\n4. Further research is required to understand the association between the moon cycle and rupture risk of intracranial aneurysms.",
    "llama-7b_fact": [
      "Some studies suggest a higher risk of intracranial aneurysm rupture during the full moon.",
      "Other studies have found no correlation between the moon cycle and rupture risk of intracranial aneurysms.",
      "It is hypothesized that the lunar cycle may affect pressure in the brain.",
      "Further research is required to understand the association between the moon cycle and rupture risk of intracranial aneurysms."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-7b_response": "Yes, HuR protein has been shown to regulate the splicing process. HuR is a nuclear protein that binds to unspliced pre-mRNA and stimulates the splicing of the mRNA. It also binds to spliced mRNA and promotes the export of the mature mRNA from the nucleus. In addition, HuR has been shown to regulate the stability of mRNA, suggesting that it may play a role in the post-transcriptional regulation of gene expression.",
    "llama-7b_fact_raw": "1. HuR protein regulates the splicing process.\n2. HuR is a nuclear protein that binds to unspliced pre-mRNA.\n3. HuR stimulates the splicing of mRNA.\n4. HuR promotes the export of mature mRNA from the nucleus.\n5. HuR has been shown to regulate the stability of mRNA.",
    "llama-7b_fact": [
      "HuR protein regulates the splicing process.",
      "HuR is a nuclear protein that binds to unspliced pre-mRNA.",
      "HuR stimulates the splicing of mRNA.",
      "HuR promotes the export of mature mRNA from the nucleus.",
      "HuR has been shown to regulate the stability of mRNA."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: HuR does not directly stimulate the splicing of mRNA, but it can influence alternative splicing by binding to certain sequences.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-7b_response": "The prothymosin alpha c-terminal peptide has been found to have a variety of functions. It has been shown to play a role in the regulation of cell growth, differentiation, and apoptosis, as well as in the regulation of the actin cytoskeleton. Additionally, it has been found to interact with a variety of proteins, including kinases, phosphatases, and transcription factors.",
    "llama-7b_fact_raw": "1. The prothymosin alpha c-terminal peptide plays a role in the regulation of cell growth.\n2. The prothymosin alpha c-terminal peptide is involved in cell differentiation.\n3. The prothymosin alpha c-terminal peptide has a function in the regulation of apoptosis.\n4. It regulates the actin cytoskeleton.\n5. The prothymosin alpha c-terminal peptide interacts with various proteins, including kinases, phosphatases, and transcription factors.",
    "llama-7b_fact": [
      "The prothymosin alpha c-terminal peptide plays a role in the regulation of cell growth.",
      "The prothymosin alpha c-terminal peptide is involved in cell differentiation.",
      "The prothymosin alpha c-terminal peptide has a function in the regulation of apoptosis.",
      "It regulates the actin cytoskeleton.",
      "The prothymosin alpha c-terminal peptide interacts with various proteins, including kinases, phosphatases, and transcription factors."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-7b_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the C-terminal domain (CTD) of cystatin C. The CTD of cystatin C is a highly conserved region that is responsible for the formation of the fibrils that are found in the nephrocytes of the kidney. It is believed that the CTD of cystatin C interacts with other cystatin C molecules to form the fibrils.",
    "llama-7b_fact_raw": "1. The C-terminal domain (CTD) of cystatin C plays a pivotal role in human cystatin C fibrillization.\n2. The CTD of cystatin C is responsible for the formation of fibrils in nephrocytes of the kidney.\n3. The CTD of cystatin C is a highly conserved region.",
    "llama-7b_fact": [
      "The C-terminal domain (CTD) of cystatin C plays a pivotal role in human cystatin C fibrillization.",
      "The CTD of cystatin C is responsible for the formation of fibrils in nephrocytes of the kidney.",
      "The CTD of cystatin C is a highly conserved region."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1 increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-7b_response": "Yes, the concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol). This is due to the fact that amifostine (ethyol) is a prodrug that is metabolized in the body to the active form of the drug, which is a potent inhibitor of the enzyme cytochrome P450 2B4. This enzyme is responsible for the degradation of HIF-1, and by inhibiting it, the concentration of HIF-1 increases.",
    "llama-7b_fact_raw": "1. The concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).\n2. Amifostine (ethyol) is metabolized in the body to its active form.\n3. The active form of amifostine (ethyol) is a potent inhibitor of the enzyme cytochrome P450 2B4.\n4. Cytochrome P450 2B4 is responsible for the degradation of HIF-1.\n5. Inhibition of cytochrome P450 2B4 leads to an increase in the concentration of HIF-1.",
    "llama-7b_fact": [
      "The concentration of protein HIF-1 increases after the administration of the cytoprotective prodrug \"amifostine\" (ethyol).",
      "Amifostine (ethyol) is metabolized in the body to its active form.",
      "The active form of amifostine (ethyol) is a potent inhibitor of the enzyme cytochrome P450 2B4.",
      "Cytochrome P450 2B4 is responsible for the degradation of HIF-1.",
      "Inhibition of cytochrome P450 2B4 leads to an increase in the concentration of HIF-1."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Note: The correctness of statements 1, 3, 4, and 5 require specific biochemical knowledge or literature confirmation about the mechanisms of action and metabolism of amifostine (ethyol), its active form, and the enzyme cytochrome P450 2B4 which is beyond general knowledge.]",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-7b_response": "Set7 is a histone methyltransferase that deposits H3K79me2 and H3K27me3 histone marks.",
    "llama-7b_fact_raw": "1. Set7 is a histone methyltransferase.\n2. Set7 deposits the histone mark H3K79me2.\n3. Set7 deposits the histone mark H3K27me3.",
    "llama-7b_fact": [
      "Set7 is a histone methyltransferase.",
      "Set7 deposits the histone mark H3K79me2.",
      "Set7 deposits the histone mark H3K27me3."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Set7 deposits the histone mark H3K4me1.\n3. FALSE [correction]: Set7 does not deposit the histone mark H3K27me3; this mark is deposited by EZH2.",
    "llama-7b_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-7b_response": "Hepcidin has two disulfide bridges.",
    "llama-7b_fact_raw": "1. Hepcidin has two disulfide bridges.",
    "llama-7b_fact": [
      "Hepcidin has two disulfide bridges."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-7b_response": "The protein encoded by the gene DNAJC11 is localized to the endoplasmic reticulum.",
    "llama-7b_fact_raw": "1. The gene DNAJC11 encodes a protein that is localized to the endoplasmic reticulum.",
    "llama-7b_fact": [
      "The gene DNAJC11 encodes a protein that is localized to the endoplasmic reticulum."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-7b_response": "Yes, ultraconserved elements (UCEs) are depleted among copy number variants (CNVs). UCEs are short segments of DNA that are highly conserved across species and are usually located in the introns of genes. CNVs are large segments of DNA that are present in more than one copy and can contain UCEs. Studies have shown that CNVs are more likely to contain UCEs than expected by chance, suggesting that UCEs are depleted among CNVs.",
    "llama-7b_fact_raw": "1. Ultraconserved elements are short segments of DNA highly conserved across species.\n2. Ultraconserved elements are typically found in the introns of genes.\n3. Copy number variants are large segments of DNA present in more than one copy.\n4. Studies suggest that copy number variants are more likely to contain ultraconserved elements than expected by chance.\n5. Ultraconserved elements are depleted among copy number variants.",
    "llama-7b_fact": [
      "Ultraconserved elements are short segments of DNA highly conserved across species.",
      "Ultraconserved elements are typically found in the introns of genes.",
      "Copy number variants are large segments of DNA present in more than one copy.",
      "Studies suggest that copy number variants are more likely to contain ultraconserved elements than expected by chance.",
      "Ultraconserved elements are depleted among copy number variants."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Ultraconserved elements are enriched among copy number variants.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-7b_response": "The haspin kinase substrate during mitosis is histone H3.",
    "llama-7b_fact_raw": "1. Haspin kinase has a substrate during mitosis.\n2. The substrate of haspin kinase during mitosis is histone H3.",
    "llama-7b_fact": [
      "Haspin kinase has a substrate during mitosis.",
      "The substrate of haspin kinase during mitosis is histone H3."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-7b_response": "Viroid replication is a process by which viroids, a class of small, non-coding, circular, single-stranded molecules of RNA, are able to reproduce themselves. The mechanism of viroid replication involves the formation of a replication complex, which consists of the viroid molecule and a helper virus. The replication complex is then able to hijack the cell's replication machinery and use it to replicate the viroid molecule. This process results in the production of a complementary strand of the viroid molecule, which is then released from the cell.",
    "llama-7b_fact_raw": "1. Viroids are a class of small, non-coding, circular, single-stranded molecules of RNA.\n2. Viroid replication involves the formation of a replication complex with a helper virus.\n3. The replication complex hijacks the cell's replication machinery to replicate the viroid molecule.\n4. The viroid replication process results in the production of a complementary strand of the viroid molecule.",
    "llama-7b_fact": [
      "Viroids are a class of small, non-coding, circular, single-stranded molecules of RNA.",
      "Viroid replication involves the formation of a replication complex with a helper virus.",
      "The replication complex hijacks the cell's replication machinery to replicate the viroid molecule.",
      "The viroid replication process results in the production of a complementary strand of the viroid molecule."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Viroid replication does not require a helper virus, as they are capable of self-replication within the host cell.\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-7b_response": "Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy. Studies have shown that fibronectin levels are significantly elevated in the serum of patients with Duchenne muscular dystrophy compared to healthy controls. Additionally, fibronectin levels have been found to be correlated with the severity of the disease. These findings suggest that fibronectin may be a useful biomarker for the diagnosis and monitoring of Duchenne muscular dystrophy.",
    "llama-7b_fact_raw": "1. Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy.\n2. Studies show that fibronectin levels are significantly elevated in the serum of patients with Duchenne muscular dystrophy compared to healthy controls.\n3. Fibronectin levels are correlated with the severity of Duchenne muscular dystrophy.",
    "llama-7b_fact": [
      "Fibronectin is a potential serum biomarker for Duchenne muscular dystrophy.",
      "Studies show that fibronectin levels are significantly elevated in the serum of patients with Duchenne muscular dystrophy compared to healthy controls.",
      "Fibronectin levels are correlated with the severity of Duchenne muscular dystrophy."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-7b_response": "The DeepBlue epigenomic data server contains data from the ENCODE, Roadmap Epigenomics, and FANTOM5 projects.",
    "llama-7b_fact_raw": "1. The ENCODE project's data is contained in the DeepBlue epigenomic data server.\n2. The Roadmap Epigenomics project's data is contained in the DeepBlue epigenomic data server.\n3. The FANTOM5 project's data is contained in the DeepBlue epigenomic data server.",
    "llama-7b_fact": [
      "The ENCODE project's data is contained in the DeepBlue epigenomic data server.",
      "The Roadmap Epigenomics project's data is contained in the DeepBlue epigenomic data server.",
      "The FANTOM5 project's data is contained in the DeepBlue epigenomic data server."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The FANTOM5 project's data is not contained in the DeepBlue epigenomic data server; it is available through the FANTOM5 data portal.",
    "llama-7b_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-7b_response": "The tool that employs self organizing maps for analyzing synonymous codon usage is CodonOptimizer.",
    "llama-7b_fact_raw": "1. CodonOptimizer is a tool that uses self organizing maps.\n2. CodonOptimizer analyzes synonymous codon usage.",
    "llama-7b_fact": [
      "CodonOptimizer is a tool that uses self organizing maps.",
      "CodonOptimizer analyzes synonymous codon usage."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-7b_response": "MINDY-1 is an AI chatbot developed by OpenAI to help humans with common language-based tasks and provide suggestions. It is trained on AI-generated dialogue data with 8 A100 GPUs and is capable of understanding and responding to questions in both English and Chinese.",
    "llama-7b_fact_raw": "1. MINDY-1 is an AI chatbot developed by OpenAI.\n2. MINDY-1 is designed to assist with language-based tasks and provide suggestions.\n3. It is trained on AI-generated dialogue data.\n4. MINDY-1 operates using 8 A100 GPUs.\n5. MINDY-1 can understand and respond to questions in English and Chinese.",
    "llama-7b_fact": [
      "MINDY-1 is an AI chatbot developed by OpenAI.",
      "MINDY-1 is designed to assist with language-based tasks and provide suggestions.",
      "It is trained on AI-generated dialogue data.",
      "MINDY-1 operates using 8 A100 GPUs.",
      "MINDY-1 can understand and respond to questions in English and Chinese."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There is no known AI chatbot called MINDY-1 developed by OpenAI.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-7b_response": "The software package available for the analysis of conserved genomic loci is BLAT (BLAST-like Alignment Tool). BLAT is a fast, flexible, and accurate alignment tool that compares genomic sequences to a reference sequence and identifies regions of similarity. It is particularly useful for identifying conserved non-coding elements in the genome.",
    "llama-7b_fact_raw": "1. BLAT stands for BLAST-like Alignment Tool.\n2. BLAT is used to compare genomic sequences to a reference sequence.\n3. BLAT can identify regions of similarity in genomic sequences.\n4. BLAT is useful for identifying conserved non-coding elements in the genome.",
    "llama-7b_fact": [
      "BLAT stands for BLAST-like Alignment Tool.",
      "BLAT is used to compare genomic sequences to a reference sequence.",
      "BLAT can identify regions of similarity in genomic sequences.",
      "BLAT is useful for identifying conserved non-coding elements in the genome."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-7b_response": "Diseases associated with the PIEZO2 gene include hereditary haemorrhagic telangiectasia (HHT), Sturge-Weber syndrome, and Klippel-Trenaunay syndrome.",
    "llama-7b_fact_raw": "1. Hereditary haemorrhagic telangiectasia (HHT) is associated with the PIEZO2 gene.\n2. Sturge-Weber syndrome is associated with the PIEZO2 gene.\n3. Klippel-Trenaunay syndrome is associated with the PIEZO2 gene.",
    "llama-7b_fact": [
      "Hereditary haemorrhagic telangiectasia (HHT) is associated with the PIEZO2 gene.",
      "Sturge-Weber syndrome is associated with the PIEZO2 gene.",
      "Klippel-Trenaunay syndrome is associated with the PIEZO2 gene."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Hereditary haemorrhagic telangiectasia (HHT) is associated with mutations in genes such as ENG, ACVRL1, and SMAD4.\n2. UNKNOWN\n3. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-7b_response": "ERAP1-ERAP2 dimerization is important for the processing and presentation of antigen by the major histocompatibility complex (MHC) class I pathway. It is believed that the dimerization of ERAP1 and ERAP2 facilitates the transfer of peptides from the ER to the cell surface, where they can be loaded onto MHC class I molecules for presentation to CD8+ T cells.",
    "llama-7b_fact_raw": "1. ERAP1-ERAP2 dimerization is important for antigen processing and presentation by the MHC class I pathway.\n2. Dimerization of ERAP1 and ERAP2 facilitates the transfer of peptides from the ER to the cell surface.\n3. Peptides are loaded onto MHC class I molecules for presentation to CD8+ T cells after being transferred to the cell surface.",
    "llama-7b_fact": [
      "ERAP1-ERAP2 dimerization is important for antigen processing and presentation by the MHC class I pathway.",
      "Dimerization of ERAP1 and ERAP2 facilitates the transfer of peptides from the ER to the cell surface.",
      "Peptides are loaded onto MHC class I molecules for presentation to CD8+ T cells after being transferred to the cell surface."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Dimerization of ERAP1 and ERAP2 facilitates the trimming of peptides in the ER before loading onto MHC class I molecules.\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-7b_response": "R-spondin 1 and noggin are both involved in the formation of the gallbladder. R-spondin 1 is a growth factor that is essential for the development of the gallbladder, while noggin is an inhibitory protein that helps to regulate the activity of R-spondin 1. In non-damaged gallbladders, R-spondin 1 and noggin work together to promote the formation and maintenance of the gallbladder.",
    "llama-7b_fact_raw": "1. R-spondin 1 is involved in the formation of the gallbladder.\n2. R-spondin 1 is a growth factor essential for gallbladder development.\n3. Noggin is an inhibitory protein that helps regulate the activity of R-spondin 1.\n4. In non-damaged gallbladders, R-spondin 1 and noggin work together to promote gallbladder formation and maintenance.",
    "llama-7b_fact": [
      "R-spondin 1 is involved in the formation of the gallbladder.",
      "R-spondin 1 is a growth factor essential for gallbladder development.",
      "Noggin is an inhibitory protein that helps regulate the activity of R-spondin 1.",
      "In non-damaged gallbladders, R-spondin 1 and noggin work together to promote gallbladder formation and maintenance."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\n[Without additional context or a specific passage to reference, the correctness of these statements regarding R-spondin 1, gallbladder development, and the protein noggin cannot be determined.]",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-7b_response": "No, NADPH oxidase 5 does not require any subunit for its function. NADPH oxidase 5 is an enzyme that catalyzes the oxidation of NADPH to generate reactive oxygen species (ROS). It is a homodimer composed of two catalytic subunits, p22phox and p40phox, and two regulatory subunits, p67phox and p47phox. The regulatory subunits are required for the enzyme to be activated, but the catalytic subunits are not. Therefore, NADPH oxidase 5 can function without any of its subunits.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-7b_response": "Furin and hepcidin are both proteins that are involved in the regulation of iron metabolism. Furin is an iron-regulatory protein that binds to hepcidin and helps to regulate the amount of iron available for absorption in the body. Hepcidin, on the other hand, is a peptide hormone that is produced by the liver and is the primary regulator of body iron homeostasis. It works by binding to the ferroportin receptor on the surface of cells and inhibiting the export of iron out of the cell, thus controlling the amount of iron available for absorption.",
    "llama-7b_fact_raw": "1. Furin is an iron-regulatory protein that binds to hepcidin.\n2. Hepcidin is a peptide hormone produced by the liver.\n3. Hepcidin is the primary regulator of body iron homeostasis.\n4. Hepcidin binds to the ferroportin receptor on cell surfaces.\n5. Hepcidin inhibits the export of iron out of cells, controlling iron absorption.",
    "llama-7b_fact": [
      "Furin is an iron-regulatory protein that binds to hepcidin.",
      "Hepcidin is a peptide hormone produced by the liver.",
      "Hepcidin is the primary regulator of body iron homeostasis.",
      "Hepcidin binds to the ferroportin receptor on cell surfaces.",
      "Hepcidin inhibits the export of iron out of cells, controlling iron absorption."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Furin is not an iron-regulatory protein; it's a protease enzyme that cleaves precursors of various proteins.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-7b_response": "The largest metabolic gene cluster in yeast is the gluconeogenesis gene cluster, which is responsible for the synthesis of glucose molecules from non-carbohydrate sources. This cluster consists of 13 genes and is located on the left arm of chromosome XII.",
    "llama-7b_fact_raw": "1. The largest metabolic gene cluster in yeast is the gluconeogenesis gene cluster.\n2. The gluconeogenesis gene cluster is responsible for the synthesis of glucose molecules from non-carbohydrate sources.\n3. The gluconeogenesis gene cluster consists of 13 genes.\n4. The gluconeogenesis gene cluster is located on the left arm of chromosome XII.",
    "llama-7b_fact": [
      "The largest metabolic gene cluster in yeast is the gluconeogenesis gene cluster.",
      "The gluconeogenesis gene cluster is responsible for the synthesis of glucose molecules from non-carbohydrate sources.",
      "The gluconeogenesis gene cluster consists of 13 genes.",
      "The gluconeogenesis gene cluster is located on the left arm of chromosome XII."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-7b_response": "LIMT is a long non-coding RNA (lncRNA) that has been shown to play a role in the regulation of cell growth and metabolism. LIMT has been found to be upregulated in a variety of cancers, and its overexpression has been linked to poor prognosis. LIMT has been shown to interact with and regulate the expression of a number of genes, including those involved in cell growth, metabolism, and epithelial-to-mesenchymal transition. These findings suggest that LIMT may be a potential therapeutic target for certain cancers.",
    "llama-7b_fact_raw": "1. LIMT is a long non-coding RNA (lncRNA).\n2. LIMT plays a role in the regulation of cell growth and metabolism.\n3. LIMT has been found to be upregulated in a variety of cancers.\n4. Overexpression of LIMT has been linked to poor prognosis in cancer patients.\n5. LIMT interacts with and regulates the expression of genes involved in cell growth, metabolism, and epithelial-to-mesenchymal transition.",
    "llama-7b_fact": [
      "LIMT is a long non-coding RNA (lncRNA).",
      "LIMT plays a role in the regulation of cell growth and metabolism.",
      "LIMT has been found to be upregulated in a variety of cancers.",
      "Overexpression of LIMT has been linked to poor prognosis in cancer patients.",
      "LIMT interacts with and regulates the expression of genes involved in cell growth, metabolism, and epithelial-to-mesenchymal transition."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-7b_response": "The R / bioconductor package used for performing SNP enrichment analysis is GREAT.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-7b_response": "The key players in radial glial specification to ependymal cells are the Sonic Hedgehog (Shh) protein, the Indian Hedgehog (Ihh) protein, and the Wnt/beta-catenin signaling pathway. Shh is a secreted protein that binds to the Patched (Ptc) receptor and activates the Indian Hedgehog (Ihh) protein. Ihh then binds to the fibroblast growth factor receptor 1 (Fgfr1) and activates the Wnt/beta-catenin signaling pathway, which is essential for radial glial specification and ependymal cell formation.",
    "llama-7b_fact_raw": "1. Sonic Hedgehog (Shh) protein is a key player in radial glial specification to ependymal cells.\n2. Indian Hedgehog (Ihh) protein is involved in the specification of radial glial cells to ependymal cells.\n3. Wnt/beta-catenin signaling pathway is essential for radial glial specification and ependymal cell formation.\n4. Shh protein binds to the Patched (Ptc) receptor and activates the Indian Hedgehog (Ihh) protein.\n5. Ihh protein binds to the fibroblast growth factor receptor 1 (Fgfr1) and activates the Wnt/beta-catenin signaling pathway.",
    "llama-7b_fact": [
      "Sonic Hedgehog (Shh) protein is a key player in radial glial specification to ependymal cells.",
      "Indian Hedgehog (Ihh) protein is involved in the specification of radial glial cells to ependymal cells.",
      "Wnt/beta-catenin signaling pathway is essential for radial glial specification and ependymal cell formation.",
      "Shh protein binds to the Patched (Ptc) receptor and activates the Indian Hedgehog (Ihh) protein.",
      "Ihh protein binds to the fibroblast growth factor receptor 1 (Fgfr1) and activates the Wnt/beta-catenin signaling pathway."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Indian Hedgehog (Ihh) protein is not involved in the specification of radial glial cells to ependymal cells.\n3. TRUE\n4. FALSE [correction]: Shh protein binds to the Patched (Ptc) receptor but does not activate the Indian Hedgehog (Ihh) protein.\n5. FALSE [correction]: Ihh protein does not bind to the fibroblast growth factor receptor 1 (Fgfr1) nor does it activate the Wnt/beta-catenin signaling pathway.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-7b_response": "Triple negative gliomas (TNGs) are characterized by the absence of three key proteins found in other gliomas: the epidermal growth factor receptor (EGFR), the anaplastic lymphoma kinase (ALK), and the platelet-derived growth factor receptor (PDGFR). These proteins are important for the growth and survival of glioma cells and their absence in TNGs makes them particularly aggressive and difficult to treat.",
    "llama-7b_fact_raw": "1. Triple negative gliomas (TNGs) lack the epidermal growth factor receptor (EGFR).\n2. Triple negative gliomas do not have the anaplastic lymphoma kinase (ALK) protein.\n3. Platelet-derived growth factor receptor (PDGFR) is absent in triple negative gliomas.\n4. The absence of EGFR, ALK, and PDGFR proteins makes TNGs aggressive and difficult to treat.",
    "llama-7b_fact": [
      "Triple negative gliomas (TNGs) lack the epidermal growth factor receptor (EGFR).",
      "Triple negative gliomas do not have the anaplastic lymphoma kinase (ALK) protein.",
      "Platelet-derived growth factor receptor (PDGFR) is absent in triple negative gliomas.",
      "The absence of EGFR, ALK, and PDGFR proteins makes TNGs aggressive and difficult to treat."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-7b_response": "TOPAZ1 is a cryptographic algorithm developed by the National Security Agency (NSA) for encrypting and decrypting data. It is a symmetric-key algorithm that uses the Advanced Encryption Standard (AES) as its core. TOPAZ1 is designed to be fast and secure, making it suitable for use in high-performance computing applications.",
    "llama-7b_fact_raw": "1. TOPAZ1 is a cryptographic algorithm developed by the National Security Agency (NSA).\n2. TOPAZ1 is used for encrypting and decrypting data.\n3. It is a symmetric-key algorithm.\n4. TOPAZ1 uses the Advanced Encryption Standard (AES) as its core.\n5. TOPAZ1 is designed for use in high-performance computing applications.",
    "llama-7b_fact": [
      "TOPAZ1 is a cryptographic algorithm developed by the National Security Agency (NSA).",
      "TOPAZ1 is used for encrypting and decrypting data.",
      "It is a symmetric-key algorithm.",
      "TOPAZ1 uses the Advanced Encryption Standard (AES) as its core.",
      "TOPAZ1 is designed for use in high-performance computing applications."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-7b_response": "The gene that controls the expression of GATA-1 isoforms is GATA-1 itself. GATA-1 is a transcription factor that encodes multiple isoforms due to alternative splicing of its mRNA. The different isoforms have different expression patterns and functions. For example, GATA-1 isoform 1 is mainly expressed in the heart and skeletal muscle, while GATA-1 isoform 2 is mainly expressed in the liver and kidney.",
    "llama-7b_fact_raw": "1. GATA-1 is the gene that controls the expression of its own isoforms.\n2. GATA-1 is a transcription factor.\n3. GATA-1 encodes multiple isoforms through alternative splicing of its mRNA.\n4. GATA-1 isoform 1 is mainly expressed in the heart and skeletal muscle.\n5. GATA-1 isoform 2 is mainly expressed in the liver and kidney.",
    "llama-7b_fact": [
      "GATA-1 is the gene that controls the expression of its own isoforms.",
      "GATA-1 is a transcription factor.",
      "GATA-1 encodes multiple isoforms through alternative splicing of its mRNA.",
      "GATA-1 isoform 1 is mainly expressed in the heart and skeletal muscle.",
      "GATA-1 isoform 2 is mainly expressed in the liver and kidney."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: GATA-1 isoform 1 is mainly expressed in erythroid cells and megakaryocytes.\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-7b_response": "MIRA-seq is a method of single-molecule sequencing developed by researchers at the Broad Institute of Harvard and MIT. It is a form of nanopore sequencing, which involves passing a single molecule of DNA or RNA through a nanopore in a membrane and measuring the electrical current that flows through the pore as the molecule passes by. The current is then used to determine the nucleotide sequence of the molecule. MIRA-seq is more accurate and faster than traditional sequencing methods, and can be used to sequence large amounts of DNA or RNA in a short amount of time.",
    "llama-7b_fact_raw": "1. MIRA-seq is a method of single-molecule sequencing.\n2. MIRA-seq was developed by researchers at the Broad Institute of Harvard and MIT.\n3. It is a form of nanopore sequencing.\n4. Nanopore sequencing involves passing a single molecule of DNA or RNA through a nanopore and measuring the electrical current.\n5. MIRA-seq is considered to be more accurate and faster than traditional sequencing methods.",
    "llama-7b_fact": [
      "MIRA-seq is a method of single-molecule sequencing.",
      "MIRA-seq was developed by researchers at the Broad Institute of Harvard and MIT.",
      "It is a form of nanopore sequencing.",
      "Nanopore sequencing involves passing a single molecule of DNA or RNA through a nanopore and measuring the electrical current.",
      "MIRA-seq is considered to be more accurate and faster than traditional sequencing methods."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: MIRA-seq is not a single-molecule sequencing method; it stands for \"methylation-interacting RNA-amplicon sequencing\" and focuses on analyzing DNA methylation.\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-7b_response": "ARCALYST is indicated for the treatment of cryopyrin-associated periodic syndromes (CAPS) in adults and children 6 years of age and older.",
    "llama-7b_fact_raw": "1. ARCALYST is used to treat cryopyrin-associated periodic syndromes (CAPS).\n2. ARCALYST can be administered to adults.\n3. ARCALYST is indicated for use in children 6 years of age and older.",
    "llama-7b_fact": [
      "ARCALYST is used to treat cryopyrin-associated periodic syndromes (CAPS).",
      "ARCALYST can be administered to adults.",
      "ARCALYST is indicated for use in children 6 years of age and older."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-7b_response": "The human acrocentric chromosomes involved in Robertsonian translocation are chromosomes 13, 14, 21, and 22.",
    "llama-7b_fact_raw": "1. Chromosome 13 is a human acrocentric chromosome involved in Robertsonian translocation.\n2. Chromosome 14 is a human acrocentric chromosome involved in Robertsonian translocation.\n3. Chromosome 21 is a human acrocentric chromosome involved in Robertsonian translocation.\n4. Chromosome 22 is a human acrocentric chromosome involved in Robertsonian translocation.",
    "llama-7b_fact": [
      "Chromosome 13 is a human acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 14 is a human acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 21 is a human acrocentric chromosome involved in Robertsonian translocation.",
      "Chromosome 22 is a human acrocentric chromosome involved in Robertsonian translocation."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-7b_response": "The R package that could be used for the identification of pediatric brain tumors is the rpart package. This package provides a range of functions for the classification and clustering of data, including the identification of pediatric brain tumors.",
    "llama-7b_fact_raw": "1. The rpart package in R can be used for the identification of pediatric brain tumors.\n2. The rpart package provides functions for classification and clustering of data.",
    "llama-7b_fact": [
      "The rpart package in R can be used for the identification of pediatric brain tumors.",
      "The rpart package provides functions for classification and clustering of data."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-7b_response": "Yes, NEMO is a zinc finger protein.",
    "llama-7b_fact_raw": "1. NEMO is a zinc finger protein.",
    "llama-7b_fact": [
      "NEMO is a zinc finger protein."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-7b_response": "Yes, TFIIS affects nucleosome positioning. TFIIS is a transcription factor that binds to the core promoter of genes and helps to recruit other transcription factors, RNA polymerase II, and other components of the transcriptional machinery. TFIIS also helps to position nucleosomes at the core promoter, which is important for proper transcriptional activation.",
    "llama-7b_fact_raw": "1. TFIIS is a transcription factor that affects nucleosome positioning.\n2. TFIIS binds to the core promoter of genes.\n3. TFIIS helps recruit other transcription factors and RNA polymerase II.\n4. TFIIS is involved in positioning nucleosomes at the core promoter for transcriptional activation.",
    "llama-7b_fact": [
      "TFIIS is a transcription factor that affects nucleosome positioning.",
      "TFIIS binds to the core promoter of genes.",
      "TFIIS helps recruit other transcription factors and RNA polymerase II.",
      "TFIIS is involved in positioning nucleosomes at the core promoter for transcriptional activation."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: TFIIS is not a transcription factor; it is a transcription elongation factor that affects RNA polymerase II activity.\n2. FALSE [correction]: TFIIS does not bind to the core promoter of genes; it interacts with RNA polymerase II during transcription elongation.\n3. TRUE\n4. FALSE [correction]: TFIIS does not position nucleosomes at the core promoter; it interacts with RNA polymerase II to facilitate transcription elongation through nucleosomes.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-7b_response": "The origins of replication that are close to yeast centromeres have been shown to fire early in the cell cycle. This is in contrast to origins of replication that are further away from the centromere, which tend to fire late in the cell cycle.",
    "llama-7b_fact_raw": "1. Origins of replication close to yeast centromeres fire early in the cell cycle.\n2. Origins of replication further away from the centromere tend to fire late in the cell cycle.",
    "llama-7b_fact": [
      "Origins of replication close to yeast centromeres fire early in the cell cycle.",
      "Origins of replication further away from the centromere tend to fire late in the cell cycle."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-7b_response": "Mammalian GA-sequences have a length of 18-20 nucleotides and are composed of three exons separated by two introns. The first exon encodes the first two amino acids of the protein, the second exon encodes the remaining amino acids, and the third exon contains the stop codon. GA-sequences are highly conserved among mammals and are important for the post-transcriptional regulation of gene expression.",
    "llama-7b_fact_raw": "1. Mammalian GA-sequences range in length from 18 to 20 nucleotides.\n2. GA-sequences consist of three exons separated by two introns.\n3. The first exon of GA-sequences encodes the first two amino acids of the protein.\n4. GA-sequences are highly conserved among mammals.\n5. GA-sequences play a role in the post-transcriptional regulation of gene expression.",
    "llama-7b_fact": [
      "Mammalian GA-sequences range in length from 18 to 20 nucleotides.",
      "GA-sequences consist of three exons separated by two introns.",
      "The first exon of GA-sequences encodes the first two amino acids of the protein.",
      "GA-sequences are highly conserved among mammals.",
      "GA-sequences play a role in the post-transcriptional regulation of gene expression."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: GA-sequences do not consist of exons and introns as they are not genes, but rather short nucleotide sequences.\n3. FALSE [correction]: Since GA-sequences are not exons, they do not encode amino acids.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-7b_response": "Four Groucho-related genes (GRG1-4) are contained in the mouse genome.",
    "llama-7b_fact_raw": "1. There are four Groucho-related genes (GRG1-4) in the mouse genome.",
    "llama-7b_fact": [
      "There are four Groucho-related genes (GRG1-4) in the mouse genome."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-7b_response": "The RNA polymerase II subunit that carries RNA cleavage activity is the C-terminal domain of the polymerase itself. This domain is responsible for the cleavage and polyadenylation of transcripts during the elongation phase of transcription.",
    "llama-7b_fact_raw": "1. The C-terminal domain of RNA polymerase II carries RNA cleavage activity.\n2. This domain is responsible for the cleavage and polyadenylation of transcripts.\n3. The cleavage and polyadenylation occur during the elongation phase of transcription.",
    "llama-7b_fact": [
      "The C-terminal domain of RNA polymerase II carries RNA cleavage activity.",
      "This domain is responsible for the cleavage and polyadenylation of transcripts.",
      "The cleavage and polyadenylation occur during the elongation phase of transcription."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The C-terminal domain of RNA polymerase II does not carry RNA cleavage activity; it serves as a platform for the assembly of factors that regulate transcription's initiation, elongation, and termination, as well as RNA processing.\n2. FALSE [correction]: Cleavage and polyadenylation factors, not the RNA polymerase II C-terminal domain itself, are responsible for the cleavage and polyadenylation of transcripts.\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-7b_response": "Ohdo syndrome is a rare genetic disorder caused by mutations in the POLD1 gene. The POLD1 gene provides instructions for making an enzyme called poly(ADP-ribose) polymerase 1, which is involved in the repair of DNA damage. Mutations in the POLD1 gene lead to an impaired ability to repair DNA damage, which can cause cellular changes that can lead to the development of Ohdo syndrome.",
    "llama-7b_fact_raw": "1. Ohdo syndrome is caused by mutations in the POLD1 gene.\n2. The POLD1 gene is responsible for making an enzyme called poly(ADP-ribose) polymerase 1.\n3. Poly(ADP-ribose) polymerase 1 is involved in the repair of DNA damage.\n4. Mutations in the POLD1 gene can impair the ability to repair DNA damage.\n5. Impaired DNA repair ability due to POLD1 gene mutations can lead to the development of Ohdo syndrome.",
    "llama-7b_fact": [
      "Ohdo syndrome is caused by mutations in the POLD1 gene.",
      "The POLD1 gene is responsible for making an enzyme called poly(ADP-ribose) polymerase 1.",
      "Poly(ADP-ribose) polymerase 1 is involved in the repair of DNA damage.",
      "Mutations in the POLD1 gene can impair the ability to repair DNA damage.",
      "Impaired DNA repair ability due to POLD1 gene mutations can lead to the development of Ohdo syndrome."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Ohdo syndrome is caused by mutations in the KAT6B gene or the MED12 gene.\n2. FALSE [correction]: The POLD1 gene is responsible for making an enzyme called DNA polymerase delta.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Impaired DNA repair ability due to POLD1 gene mutations can lead to increased risk of cancer, not necessarily Ohdo syndrome. Ohdo syndrome is associated with mutations in the KAT6B or MED12 genes.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-7b_response": "The R/Bioconductor package \"psychiatric-disease-genes\" has been developed for the analysis of psychiatric disease genes.",
    "llama-7b_fact_raw": "1. The R/Bioconductor package developed for the analysis of psychiatric disease genes is named \"psychiatric-disease-genes\".",
    "llama-7b_fact": [
      "The R/Bioconductor package developed for the analysis of psychiatric disease genes is named \"psychiatric-disease-genes\"."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The R/Bioconductor package developed for the analysis of psychiatric disease genes is named \"PsychiatricDiseaseGenes\".",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-7b_response": "Swirl sign is a characteristic finding on computed tomography (CT) scans of intracerebral hemorrhages. It is caused by the rapid flow of blood within the hemorrhage, which creates a swirling pattern that looks like a tornado. This sign is highly specific for intracerebral hemorrhage and can help differentiate it from other causes of stroke.",
    "llama-7b_fact_raw": "1. Swirl sign is a finding on computed tomography (CT) scans.\n2. Swirl sign is indicative of intracerebral hemorrhage.\n3. Swirl sign appears due to the rapid flow of blood within the hemorrhage.\n4. Swirl sign resembles a swirling pattern similar to a tornado.\n5. Swirl sign helps differentiate intracerebral hemorrhage from other causes of stroke.",
    "llama-7b_fact": [
      "Swirl sign is a finding on computed tomography (CT) scans.",
      "Swirl sign is indicative of intracerebral hemorrhage.",
      "Swirl sign appears due to the rapid flow of blood within the hemorrhage.",
      "Swirl sign resembles a swirling pattern similar to a tornado.",
      "Swirl sign helps differentiate intracerebral hemorrhage from other causes of stroke."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Swirl sign appears due to mixing of blood with cerebrospinal fluid or layering of blood components within the hemorrhage.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-7b_response": "ROF1 expression in Arabidopsis thaliana is induced by abscisic acid (ABA), a phytohormone involved in the response to environmental stress. ABA binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter, leading to transcriptional activation of the ROF1 gene. Other environmental stresses, such as high salinity, also induce ROF1 expression.",
    "llama-7b_fact_raw": "1. ROF1 expression in Arabidopsis thaliana is induced by abscisic acid (ABA).\n2. Abscisic acid (ABA) is a phytohormone involved in the response to environmental stress.\n3. ABA binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter.\n4. The activation of ABRE leads to transcriptional activation of the ROF1 gene.\n5. High salinity is an environmental stress that induces ROF1 expression.",
    "llama-7b_fact": [
      "ROF1 expression in Arabidopsis thaliana is induced by abscisic acid (ABA).",
      "Abscisic acid (ABA) is a phytohormone involved in the response to environmental stress.",
      "ABA binds to and activates the ABA-responsive element (ABRE) in the ROF1 promoter.",
      "The activation of ABRE leads to transcriptional activation of the ROF1 gene.",
      "High salinity is an environmental stress that induces ROF1 expression."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-7b_response": "The most common cause of hereditary renal amyloidosis is a mutation in the transthyretin (TTR) gene. TTR is a plasma protein that is involved in the transport of thyroid hormones and vitamin A throughout the body. When the TTR gene is mutated, it can cause the production of an abnormal, misfolded protein that accumulates in the kidneys, resulting in renal amyloidosis.",
    "llama-7b_fact_raw": "1. Hereditary renal amyloidosis is most commonly caused by a mutation in the transthyretin (TTR) gene.\n2. Transthyretin is a plasma protein involved in the transport of thyroid hormones and vitamin A.\n3. A mutated TTR gene can lead to the production of an abnormal, misfolded protein.\n4. The misfolded protein associated with a TTR gene mutation accumulates in the kidneys.\n5. Accumulation of this abnormal protein in the kidneys results in renal amyloidosis.",
    "llama-7b_fact": [
      "Hereditary renal amyloidosis is most commonly caused by a mutation in the transthyretin (TTR) gene.",
      "Transthyretin is a plasma protein involved in the transport of thyroid hormones and vitamin A.",
      "A mutated TTR gene can lead to the production of an abnormal, misfolded protein.",
      "The misfolded protein associated with a TTR gene mutation accumulates in the kidneys.",
      "Accumulation of this abnormal protein in the kidneys results in renal amyloidosis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Hereditary renal amyloidosis is most commonly caused by mutations in the genes encoding fibrinogen A alpha-chain, apolipoprotein A-I, apolipoprotein A-II, or lysozyme, not the TTR gene.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-7b_response": "Yes, the proteome of mice hippocampus has been analysed. A study published in 2013 by the journal Molecular and Cellular Proteomics reported the results of a proteomic analysis of the hippocampus of mice. The study identified over 11,000 proteins and characterized the expression of over 5,600 of them.",
    "llama-7b_fact_raw": "1. The proteome of mice hippocampus has been analysed.\n2. A study on the proteomic analysis of the hippocampus of mice was published in 2013.\n3. The study was published in the journal Molecular and Cellular Proteomics.\n4. The study identified over 11,000 proteins in the hippocampus of mice.\n5. The study characterized the expression of over 5,600 proteins in the hippocampus of mice.",
    "llama-7b_fact": [
      "The proteome of mice hippocampus has been analysed.",
      "A study on the proteomic analysis of the hippocampus of mice was published in 2013.",
      "The study was published in the journal Molecular and Cellular Proteomics.",
      "The study identified over 11,000 proteins in the hippocampus of mice.",
      "The study characterized the expression of over 5,600 proteins in the hippocampus of mice."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-7b_response": "No, mouse chromosomes are not acrocentric.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-7b_response": "The siRNA based drug currently in clinical trials for the treatment of pancreatic cancer is GEN-1, which is being developed by Genocea Biosciences. GEN-1 is an investigational RNA interference (RNAi) therapeutic that is designed to silence the genes that cause pancreatic cancer. It is believed that by silencing these genes, the growth of pancreatic cancer cells can be stopped. GEN-1 is currently in Phase I/II clinical trials.",
    "llama-7b_fact_raw": "1. GEN-1 is an siRNA based drug in clinical trials for the treatment of pancreatic cancer.\n2. Genocea Biosciences is developing GEN-1.\n3. GEN-1 is an investigational RNA interference (RNAi) therapeutic.\n4. GEN-1 is designed to silence the genes that cause pancreatic cancer.\n5. GEN-1 is currently in Phase I/II clinical trials.",
    "llama-7b_fact": [
      "GEN-1 is an siRNA based drug in clinical trials for the treatment of pancreatic cancer.",
      "Genocea Biosciences is developing GEN-1.",
      "GEN-1 is an investigational RNA interference (RNAi) therapeutic.",
      "GEN-1 is designed to silence the genes that cause pancreatic cancer.",
      "GEN-1 is currently in Phase I/II clinical trials."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-7b_response": "The HPG pore is a small hole in the cell membrane of plant cells that is used for the transport of materials in and out of the cell. It is located in the plasma membrane of the cell and is responsible for the movement of water, minerals, and other nutrients in and out of the cell. It is also responsible for the movement of certain molecules, such as hormones and signalling molecules, which are important for the communication between cells.",
    "llama-7b_fact_raw": "1. The HPG pore is a small hole in the cell membrane of plant cells.\n2. It is used for the transport of materials in and out of the cell.\n3. The HPG pore is located in the plasma membrane of the cell.\n4. The HPG pore is responsible for the movement of water, minerals, and other nutrients in and out of the cell.\n5. It is also responsible for the movement of certain molecules such as hormones and signalling molecules.",
    "llama-7b_fact": [
      "The HPG pore is a small hole in the cell membrane of plant cells.",
      "It is used for the transport of materials in and out of the cell.",
      "The HPG pore is located in the plasma membrane of the cell.",
      "The HPG pore is responsible for the movement of water, minerals, and other nutrients in and out of the cell.",
      "It is also responsible for the movement of certain molecules such as hormones and signalling molecules."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The HPG pore is not a recognized structure in plant cells. It might be a confusion with plasmodesmata, which are pores in the cell wall of plant cells.\n2. UNKNOWN (The correct structure responsible for transport might be plasmodesmata or other cellular structures such as cell membrane transport proteins)\n3. UNKNOWN (As HPG pore is not a recognized structure, its location cannot be determined)\n4. UNKNOWN (The movement of water, minerals, and other nutrients is typically associated with different cellular structures such as plasmodesmata, vacuoles, or transport proteins in the cell membrane)\n5. UNKNOWN (Movement of hormones and signalling molecules is a function generally associated with various cellular structures and mechanisms, not specifically the HPG pore)",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-7b_response": "The 959 Nematode Genomes initiative is a research project that aims to sequence and analyze the genomes of 959 species of roundworms, or nematodes. This project is being conducted by the Nematode Genomics Consortium, a collaboration of researchers from around the world, and is funded by the National Institutes of Health. The goal of the project is to gain a better understanding of the diversity of nematodes and their role in the environment, as well as to identify potential new treatments for human diseases.",
    "llama-7b_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms.\n2. The Nematode Genomics Consortium is conducting the project.\n3. Researchers from around the world are collaborating on the project.\n4. The National Institutes of Health is funding the project.\n5. The project aims to understand the diversity of nematodes and their role in the environment and identify potential new treatments for human diseases.",
    "llama-7b_fact": [
      "The 959 Nematode Genomes initiative aims to sequence and analyze the genomes of 959 species of roundworms.",
      "The Nematode Genomics Consortium is conducting the project.",
      "Researchers from around the world are collaborating on the project.",
      "The National Institutes of Health is funding the project.",
      "The project aims to understand the diversity of nematodes and their role in the environment and identify potential new treatments for human diseases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-7b_response": "The R package 'NIPT' has been developed for analyzing Non-invasive prenatal testing (NIPT) data. It provides functions for data pre-processing, quality control, and statistical analysis of NIPT data.",
    "llama-7b_fact_raw": "1. The R package 'NIPT' is developed for analyzing Non-invasive prenatal testing (NIPT) data.\n2. The 'NIPT' package includes functions for data pre-processing.\n3. The 'NIPT' package includes functions for quality control.\n4. The 'NIPT' package includes functions for statistical analysis of NIPT data.",
    "llama-7b_fact": [
      "The R package 'NIPT' is developed for analyzing Non-invasive prenatal testing (NIPT) data.",
      "The 'NIPT' package includes functions for data pre-processing.",
      "The 'NIPT' package includes functions for quality control.",
      "The 'NIPT' package includes functions for statistical analysis of NIPT data."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbachs syndrome.",
    "llama-7b_response": "Achenbach's syndrome is a rare genetic disorder that affects the skin, hair, and nails. It is characterized by abnormal pigmentation of the skin, white patches on the skin, sparse and broken hair, and brittle and discolored nails. It is caused by mutations in the MC1R gene and is inherited in an autosomal dominant manner.",
    "llama-7b_fact_raw": "1. Achenbach's syndrome is a genetic disorder that affects the skin, hair, and nails.\n2. The syndrome is characterized by abnormal pigmentation of the skin.\n3. White patches on the skin are a symptom of Achenbach's syndrome.\n4. Achenbach's syndrome can cause sparse and broken hair.\n5. Brittle and discolored nails are associated with Achenbach's syndrome.\n6. Mutations in the MC1R gene cause Achenbach's syndrome.\n7. Achenbach's syndrome is inherited in an autosomal dominant manner.",
    "llama-7b_fact": [
      "Achenbach's syndrome is a genetic disorder that affects the skin, hair, and nails.",
      "The syndrome is characterized by abnormal pigmentation of the skin.",
      "White patches on the skin are a symptom of Achenbach's syndrome.",
      "Achenbach's syndrome can cause sparse and broken hair.",
      "Brittle and discolored nails are associated with Achenbach's syndrome.",
      "Mutations in the MC1R gene cause Achenbach's syndrome.",
      "Achenbach's syndrome is inherited in an autosomal dominant manner."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is not a genetic disorder; it is a rare condition that causes spontaneous bruising of the hands or fingers.\n2. FALSE [correction]: Achenbach's syndrome does not involve abnormal pigmentation of the skin, it is characterized by spontaneous bruising.\n3. FALSE [correction]: White patches on the skin are not a symptom of Achenbach's syndrome.\n4. UNKNOWN\n5. UNKNOWN\n6. FALSE [correction]: Achenbach's syndrome is not caused by mutations in the MC1R gene; the cause is not well understood.\n7. FALSE [correction]: Achenbach's syndrome is not inherited in an autosomal dominant manner as it is not a genetic condition.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-7b_response": "The algorithm used for detection of long repeat expansions is the Sliding Window Algorithm. This algorithm is used to detect the presence of a long repeat expansion in a given sequence of nucleotides. It works by scanning the sequence for the presence of a given number of identical nucleotides in a window of a given size. If the window contains the given number of identical nucleotides, then a repeat expansion is detected.",
    "llama-7b_fact_raw": "1. The Sliding Window Algorithm is used for detection of long repeat expansions.\n2. The Sliding Window Algorithm detects repeat expansions by scanning a sequence for a given number of identical nucleotides.\n3. The Sliding Window Algorithm operates within a window of a specified size.",
    "llama-7b_fact": [
      "The Sliding Window Algorithm is used for detection of long repeat expansions.",
      "The Sliding Window Algorithm detects repeat expansions by scanning a sequence for a given number of identical nucleotides.",
      "The Sliding Window Algorithm operates within a window of a specified size."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-7b_response": "Neuroligin-3 has been found to promote the growth of low-grade gliomas, such as astrocytomas and oligodendrogliomas, as well as medulloblastomas.",
    "llama-7b_fact_raw": "1. Neuroligin-3 promotes the growth of low-grade gliomas.\n2. Neuroligin-3 has been found to promote the growth of astrocytomas.\n3. Neuroligin-3 promotes the growth of oligodendrogliomas.\n4. Neuroligin-3 has been found to promote the growth of medulloblastomas.",
    "llama-7b_fact": [
      "Neuroligin-3 promotes the growth of low-grade gliomas.",
      "Neuroligin-3 has been found to promote the growth of astrocytomas.",
      "Neuroligin-3 promotes the growth of oligodendrogliomas.",
      "Neuroligin-3 has been found to promote the growth of medulloblastomas."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Neuroligin-3 has not been found to promote the growth of medulloblastomas.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-7b_response": "The approximate size of gas vesicles varies depending on the species, but they are typically around 1-2 m in diameter.",
    "llama-7b_fact_raw": "1. Gas vesicles typically have a diameter of around 1-2 m.",
    "llama-7b_fact": [
      "Gas vesicles typically have a diameter of around 1-2 m."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-7b_response": "BET proteins are a family of proteins that are involved in the regulation of transcription. The BET proteins are composed of three subunits, BET1, BET2, and BET3. BET1 and BET3 form a homodimer, while BET2 binds to BET1 and BET3 to form a heterodimer. The BET proteins are involved in the regulation of gene expression by recognizing acetylated histones and other nuclear factors. They are also involved in the transcriptional activation of genes involved in cell growth, differentiation, and development.",
    "llama-7b_fact_raw": "1. BET proteins are a family of proteins involved in the regulation of transcription.\n2. The BET protein family consists of three subunits: BET1, BET2, and BET3.\n3. BET1 and BET3 can form a homodimer.\n4. BET2 binds to BET1 and BET3 to form a heterodimer.\n5. BET proteins regulate gene expression by recognizing acetylated histones and other nuclear factors.",
    "llama-7b_fact": [
      "BET proteins are a family of proteins involved in the regulation of transcription.",
      "The BET protein family consists of three subunits: BET1, BET2, and BET3.",
      "BET1 and BET3 can form a homodimer.",
      "BET2 binds to BET1 and BET3 to form a heterodimer.",
      "BET proteins regulate gene expression by recognizing acetylated histones and other nuclear factors."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The BET protein family consists of four subunits: BRD2, BRD3, BRD4, and BRDT.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-7b_response": "The algorithm for prediction of protein subcellular localization using deep learning is called Deep Subcellular Localization (DSL). It was developed by Zhang et al. in 2018 and uses a deep convolutional neural network (CNN) to predict the subcellular localization of a protein from its amino acid sequence.",
    "llama-7b_fact_raw": "1. Deep Subcellular Localization (DSL) is an algorithm for prediction of protein subcellular localization using deep learning.\n2. The DSL algorithm was developed by Zhang et al. in 2018.\n3. The DSL algorithm uses a deep convolutional neural network (CNN).\n4. The DSL algorithm predicts the subcellular localization of a protein from its amino acid sequence.",
    "llama-7b_fact": [
      "Deep Subcellular Localization (DSL) is an algorithm for prediction of protein subcellular localization using deep learning.",
      "The DSL algorithm was developed by Zhang et al. in 2018.",
      "The DSL algorithm uses a deep convolutional neural network (CNN).",
      "The DSL algorithm predicts the subcellular localization of a protein from its amino acid sequence."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-7b_response": "MULTOVL is an AI-powered virtual assistant that helps humans by performing common language-based tasks and providing suggestions. It is trained on AI-generated dialogue data with 8 A100 GPUs and is capable of understanding and responding to questions in both English and Chinese.",
    "llama-7b_fact_raw": "1. MULTOVL is a virtual assistant powered by artificial intelligence.\n2. MULTOVL performs language-based tasks and provides suggestions.\n3. MULTOVL is trained on AI-generated dialogue data.\n4. MULTOVL operates with 8 A100 GPUs.\n5. MULTOVL can understand and respond to questions in both English and Chinese.",
    "llama-7b_fact": [
      "MULTOVL is a virtual assistant powered by artificial intelligence.",
      "MULTOVL performs language-based tasks and provides suggestions.",
      "MULTOVL is trained on AI-generated dialogue data.",
      "MULTOVL operates with 8 A100 GPUs.",
      "MULTOVL can understand and respond to questions in both English and Chinese."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-7b_response": "GDF15 is a biomarker that can be used to measure the effectiveness of metformin treatment. Metformin is an anti-diabetic drug that has been shown to reduce levels of GDF15 in patients with type 2 diabetes. Therefore, measuring the level of GDF15 in a patient's blood can be used as a biomarker to determine whether the patient is responding to metformin treatment.",
    "llama-7b_fact_raw": "1. GDF15 is a biomarker used to measure the effectiveness of metformin treatment.\n2. Metformin is an anti-diabetic drug.\n3. Metformin has been shown to reduce levels of GDF15 in patients with type 2 diabetes.\n4. The level of GDF15 in a patient's blood can indicate response to metformin treatment.",
    "llama-7b_fact": [
      "GDF15 is a biomarker used to measure the effectiveness of metformin treatment.",
      "Metformin is an anti-diabetic drug.",
      "Metformin has been shown to reduce levels of GDF15 in patients with type 2 diabetes.",
      "The level of GDF15 in a patient's blood can indicate response to metformin treatment."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Metformin has been shown to increase levels of GDF15 in patients with type 2 diabetes.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-7b_response": "Recursive splicing is more common in short introns than in long introns. This is because short introns are more likely to contain exonic splicing enhancers (ESEs) and intronic splicing enhancers (ISEs), which are elements that help promote the recruitment of the splicing machinery and thus increase the likelihood of recursive splicing. Additionally, short introns are more likely to contain splicing regulatory elements (SREs) which can also promote recursive splicing.",
    "llama-7b_fact_raw": "1. Recursive splicing is more common in short introns than in long introns.\n2. Short introns are more likely to contain exonic splicing enhancers (ESEs).\n3. Short introns are more likely to contain intronic splicing enhancers (ISEs).\n4. Splicing machinery recruitment is promoted by exonic and intronic splicing enhancers.\n5. Short introns are more likely to contain splicing regulatory elements (SREs) which promote recursive splicing.",
    "llama-7b_fact": [
      "Recursive splicing is more common in short introns than in long introns.",
      "Short introns are more likely to contain exonic splicing enhancers (ESEs).",
      "Short introns are more likely to contain intronic splicing enhancers (ISEs).",
      "Splicing machinery recruitment is promoted by exonic and intronic splicing enhancers.",
      "Short introns are more likely to contain splicing regulatory elements (SREs) which promote recursive splicing."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Recursive splicing is more common in long introns than in short introns.\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: Short introns are less likely to promote recursive splicing as compared to long introns, which contain more splicing regulatory elements (SREs) that promote recursive splicing.",
    "llama-7b_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-7b_response": "The TALE-iD method is used to identify and characterize transcription factor binding sites in a genome. It is an acronym for Transcription Factor Binding Site Identification by Integrated Discovery. This method uses a combination of data sources, such as ChIP-seq, RNA-seq, and genome-wide association studies, to identify and characterize transcription factor binding sites in a genome.",
    "llama-7b_fact_raw": "1. The TALE-iD method is used to identify transcription factor binding sites in a genome.\n2. TALE-iD stands for Transcription Factor Binding Site Identification by Integrated Discovery.\n3. The method involves using data from sources like ChIP-seq, RNA-seq, and genome-wide association studies.",
    "llama-7b_fact": [
      "The TALE-iD method is used to identify transcription factor binding sites in a genome.",
      "TALE-iD stands for Transcription Factor Binding Site Identification by Integrated Discovery.",
      "The method involves using data from sources like ChIP-seq, RNA-seq, and genome-wide association studies."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: TALE-iD stands for Transposon-based Analysis of Loci that Enhance or Silence Gene Expression by Integrated Discovery.\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-7b_response": "The Common Lisp Image Processing (CLISP) framework has been developed for image processing. CLISP is a portable, object-oriented image processing library written in Common Lisp. It provides a wide range of functions for image manipulation, including image loading, image conversion, image filtering, and image analysis.",
    "llama-7b_fact_raw": "1. Common Lisp Image Processing (CLISP) framework is developed for image processing.\n2. CLISP is written in Common Lisp.\n3. CLISP is a portable, object-oriented image processing library.\n4. CLISP offers functions for image manipulation such as loading, conversion, filtering, and analysis.",
    "llama-7b_fact": [
      "Common Lisp Image Processing (CLISP) framework is developed for image processing.",
      "CLISP is written in Common Lisp.",
      "CLISP is a portable, object-oriented image processing library.",
      "CLISP offers functions for image manipulation such as loading, conversion, filtering, and analysis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Common Lisp Interface Manager (CLIM) framework is developed for user interfaces, not image processing.\n2. TRUE\n3. FALSE [correction]: CLISP refers to an implementation of the Common Lisp language, not an image processing library.\n4. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-7b_response": "Approximately 70% of the genes in the budding yeast Saccharomyces cerevisiae are the result of an ancient whole genome duplication event that occurred approximately 10 million years ago. This event resulted in the duplication of the entire genome, creating two identical copies of each gene.",
    "llama-7b_fact_raw": "1. Around 70% of the genes in Saccharomyces cerevisiae are from an ancient whole genome duplication event.\n2. The whole genome duplication event occurred approximately 10 million years ago.\n3. The event duplicated the entire genome of Saccharomyces cerevisiae, creating two identical copies of each gene.",
    "llama-7b_fact": [
      "Around 70% of the genes in Saccharomyces cerevisiae are from an ancient whole genome duplication event.",
      "The whole genome duplication event occurred approximately 10 million years ago.",
      "The event duplicated the entire genome of Saccharomyces cerevisiae, creating two identical copies of each gene."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The whole genome duplication event occurred approximately 100 million years ago.\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor  (Esrrb)?",
    "llama-7b_response": "Estrogen-related receptor  (Esrrb) binds the estrogen receptor complex. The estrogen receptor complex is composed of estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2). ESR1 and ESR2 work together to regulate the expression of genes that are involved in the development and maintenance of the female reproductive system, as well as other tissues and organs.",
    "llama-7b_fact_raw": "1. Estrogen-related receptor  (Esrrb) binds the estrogen receptor complex.\n2. The estrogen receptor complex is composed of estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2).\n3. ESR1 and ESR2 regulate the expression of genes involved in the development and maintenance of the female reproductive system.\n4. ESR1 and ESR2 also regulate genes involved in other tissues and organs.",
    "llama-7b_fact": [
      "Estrogen-related receptor  (Esrrb) binds the estrogen receptor complex.",
      "The estrogen receptor complex is composed of estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2).",
      "ESR1 and ESR2 regulate the expression of genes involved in the development and maintenance of the female reproductive system.",
      "ESR1 and ESR2 also regulate genes involved in other tissues and organs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Estrogen-related receptor  (Esrrb) does not bind the estrogen receptor complex; it is a distinct nuclear receptor that can be activated independently of estrogen.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-7b_response": "ZCCHC17 is a member of the zinc finger CCCH-type family and is involved in the regulation of transcription. It binds to the promoter region of genes and helps to activate or repress their transcription. ZCCHC17 has been shown to play a role in the development and function of the immune system, as well as in the regulation of cell growth and metabolism.",
    "llama-7b_fact_raw": "1. ZCCHC17 is a member of the zinc finger CCCH-type family.\n2. ZCCHC17 is involved in the regulation of transcription.\n3. ZCCHC17 binds to the promoter region of genes.\n4. ZCCHC17 plays a role in the development and function of the immune system.\n5. ZCCHC17 is involved in the regulation of cell growth and metabolism.",
    "llama-7b_fact": [
      "ZCCHC17 is a member of the zinc finger CCCH-type family.",
      "ZCCHC17 is involved in the regulation of transcription.",
      "ZCCHC17 binds to the promoter region of genes.",
      "ZCCHC17 plays a role in the development and function of the immune system.",
      "ZCCHC17 is involved in the regulation of cell growth and metabolism."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-7b_response": "The proteins that form the nuclear pore basket in human cells are nucleoporins. Nucleoporins are a family of proteins that form the structural framework of the nuclear pore complex, a large protein channel in the nuclear membrane that serves as a gateway for transport of molecules between the nucleus and the cytoplasm. Nucleoporins are composed of multiple copies of a few different types of proteins, each of which has a distinct function in the assembly and maintenance of the nuclear pore complex.",
    "llama-7b_fact_raw": "1. Nucleoporins form the nuclear pore basket in human cells.\n2. Nucleoporins are a family of proteins that provide the structural framework of the nuclear pore complex.\n3. The nuclear pore complex is a protein channel in the nuclear membrane.\n4. The nuclear pore complex facilitates transport of molecules between the nucleus and the cytoplasm.\n5. Nucleoporins are composed of multiple copies of different types of proteins.",
    "llama-7b_fact": [
      "Nucleoporins form the nuclear pore basket in human cells.",
      "Nucleoporins are a family of proteins that provide the structural framework of the nuclear pore complex.",
      "The nuclear pore complex is a protein channel in the nuclear membrane.",
      "The nuclear pore complex facilitates transport of molecules between the nucleus and the cytoplasm.",
      "Nucleoporins are composed of multiple copies of different types of proteins."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Nucleoporins are part of the nuclear pore complex but do not form the nuclear pore basket specifically.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-7b_response": "Gepotidacin is a type of topoisomerase II inhibitor.",
    "llama-7b_fact_raw": "1. Gepotidacin is a topoisomerase II inhibitor.",
    "llama-7b_fact": [
      "Gepotidacin is a topoisomerase II inhibitor."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-7b_response": "Canvas SPW is an AI-powered platform that helps businesses automate their customer service processes. It uses natural language processing (NLP) and machine learning (ML) technologies to understand customer inquiries and provide personalized, automated responses. Canvas SPW can be integrated with existing customer service systems, such as chatbots, to provide a more comprehensive customer service experience.",
    "llama-7b_fact_raw": "1. Canvas SPW is an AI-powered platform designed for automating customer service processes.\n2. Canvas SPW utilizes natural language processing (NLP) and machine learning (ML) technologies.\n3. The platform can understand customer inquiries and provide personalized, automated responses.\n4. Canvas SPW can be integrated with existing customer service systems, including chatbots.",
    "llama-7b_fact": [
      "Canvas SPW is an AI-powered platform designed for automating customer service processes.",
      "Canvas SPW utilizes natural language processing (NLP) and machine learning (ML) technologies.",
      "The platform can understand customer inquiries and provide personalized, automated responses.",
      "Canvas SPW can be integrated with existing customer service systems, including chatbots."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-7b_response": "STING agonists are molecules that bind to and activate the Stimulator of Interferon Genes (STING) protein. Examples of STING agonists include, but are not limited to, cyclic dinucleotides (CDNs) such as cyclic di-GMP (c-di-GMP) and cyclic di-AMP (c-di-AMP), as well as synthetic small molecules, peptides, and antibodies.",
    "llama-7b_fact_raw": "1. STING agonists bind to and activate the STING protein.\n2. Cyclic dinucleotides (CDNs) are examples of STING agonists.\n3. Cyclic di-GMP (c-di-GMP) is a type of CDN that acts as a STING agonist.\n4. Cyclic di-AMP (c-di-AMP) is another type of CDN that acts as a STING agonist.\n5. Synthetic small molecules, peptides, and antibodies can also function as STING agonists.",
    "llama-7b_fact": [
      "STING agonists bind to and activate the STING protein.",
      "Cyclic dinucleotides (CDNs) are examples of STING agonists.",
      "Cyclic di-GMP (c-di-GMP) is a type of CDN that acts as a STING agonist.",
      "Cyclic di-AMP (c-di-AMP) is another type of CDN that acts as a STING agonist.",
      "Synthetic small molecules, peptides, and antibodies can also function as STING agonists."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-7b_response": "SLIC-CAGE is a method used to classify proteins based on their structure. It stands for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry. This method takes into account the secondary structure of the protein, the number of loops, the isoelectric point, and the ratio of cysteine and aspartic acid residues in order to classify proteins into distinct categories.",
    "llama-7b_fact_raw": "1. SLIC-CAGE is a method for classifying proteins.\n2. SLIC-CAGE stands for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry.\n3. The method considers the secondary structure of proteins.\n4. It takes into account the number of loops in proteins.\n5. SLIC-CAGE uses the ratio of cysteine and aspartic acid residues for protein classification.",
    "llama-7b_fact": [
      "SLIC-CAGE is a method for classifying proteins.",
      "SLIC-CAGE stands for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry.",
      "The method considers the secondary structure of proteins.",
      "It takes into account the number of loops in proteins.",
      "SLIC-CAGE uses the ratio of cysteine and aspartic acid residues for protein classification."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: SLIC-CAGE does not stand for Secondary Structure, Loop Content, Isoelectric Point, and Cysteine/Aspartic Acid Ratio in the Context of Amino Acid Geometry.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-7b_response": "LEM-3 is a protein that plays a role in the regulation of cell growth and division. It is a member of the LIM-only protein family, which is characterized by the presence of two LIM domains. LIM domains are protein-binding domains that are involved in the regulation of a variety of cellular processes, such as cell adhesion, gene transcription, and cell growth. In particular, LEM-3 is thought to be involved in the regulation of the cell cycle, as well as in the formation of the mitotic spindle and the assembly of the mitotic apparatus.",
    "llama-7b_fact_raw": "1. LEM-3 is a protein that regulates cell growth and division.\n2. LEM-3 is a member of the LIM-only protein family.\n3. The LIM-only protein family is characterized by the presence of two LIM domains.\n4. LIM domains are involved in the regulation of cellular processes including cell adhesion, gene transcription, and cell growth.\n5. LEM-3 is thought to be involved in the regulation of the cell cycle and the formation of the mitotic spindle and assembly of the mitotic apparatus.",
    "llama-7b_fact": [
      "LEM-3 is a protein that regulates cell growth and division.",
      "LEM-3 is a member of the LIM-only protein family.",
      "The LIM-only protein family is characterized by the presence of two LIM domains.",
      "LIM domains are involved in the regulation of cellular processes including cell adhesion, gene transcription, and cell growth.",
      "LEM-3 is thought to be involved in the regulation of the cell cycle and the formation of the mitotic spindle and assembly of the mitotic apparatus."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: LEM-3 is not a member of the LIM-only protein family, it belongs to the LEM domain protein family.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-7b_response": "The releases of tmVar are: 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 1.10, 1.11, 1.12, 1.13, 1.14, 1.15, 1.16, 1.17, 1.18, 1.19, 1.20, 1.21, 1.22, 1.23, 1.24, 1.25, 1.26, 1.27, 1.28, 1.29, 1.30, 1.31, 1.32, 1.33, 1.34, 1.35, 1.36, 1.37, 1.38, 1.39, 1.40, 1.41, 1.42, 1.43, 1.44, 1.45, 1.46, 1.47, 1.48, 1.49, 1.50, 1.51, 1.52, 1.53, 1.54, 1.55, 1.56, 1.57, 1.58, 1.59, 1.60, 1.61, 1.62, 1.63, 1.64, 1.65, 1.66, 1.67, 1.68, 1.69, 1.70, 1.71, 1.72, 1.73, 1.74, 1.75, 1.76, 1.77, 1.78, 1.79, 1.80, 1.81, 1.82, 1.83, 1.84, 1.85",
    "llama-7b_fact_raw": "1. tmVar has a release version 1.0.\n2. tmVar has a release version 1.1.\n3. tmVar has a release version 1.2.\n4. tmVar has a release version 1.3.\n5. tmVar has a release version 1.4.",
    "llama-7b_fact": [
      "tmVar has a release version 1.0.",
      "tmVar has a release version 1.1.",
      "tmVar has a release version 1.2.",
      "tmVar has a release version 1.3.",
      "tmVar has a release version 1.4."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Note: Without additional context or knowledge about tmVar and its release history, it is not possible to determine the truthfulness of these statements.]",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-7b_response": "The database of somatic mutations in normal cells is known as the Catalog of Somatic Mutations in Cancer (COSMIC). It is a comprehensive database of somatic mutations in normal cells and cancer cells, which is maintained and updated by the Wellcome Sanger Institute. COSMIC provides detailed information about the types of mutations, their frequencies, and the tissues in which they occur.",
    "llama-7b_fact_raw": "1. The Catalog of Somatic Mutations in Cancer (COSMIC) is a database of somatic mutations in normal cells.\n2. COSMIC also includes information on somatic mutations in cancer cells.\n3. The Wellcome Sanger Institute maintains and updates the COSMIC database.\n4. COSMIC provides information about the types of mutations, their frequencies, and the tissues where they occur.",
    "llama-7b_fact": [
      "The Catalog of Somatic Mutations in Cancer (COSMIC) is a database of somatic mutations in normal cells.",
      "COSMIC also includes information on somatic mutations in cancer cells.",
      "The Wellcome Sanger Institute maintains and updates the COSMIC database.",
      "COSMIC provides information about the types of mutations, their frequencies, and the tissues where they occur."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Catalog of Somatic Mutations in Cancer (COSMIC) is a database of somatic mutations in cancer cells, not normal cells.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-7b_response": "Yes, there are several graph kernel libraries available that are implemented in JAVA. These include the JGraphT library, the GraphBLAS library, and the JKernel library. JGraphT is a library for the manipulation of graphs and is written in Java and C++. GraphBLAS is a library for the manipulation of graphs and is written in Java and C++. JKernel is a library for the implementation of graph kernels and is written in Java.",
    "llama-7b_fact_raw": "1. JGraphT is a library for the manipulation of graphs implemented in Java and C++.\n2. GraphBLAS is a library for the manipulation of graphs implemented in Java and C++.\n3. JKernel is a library for the implementation of graph kernels implemented in Java.",
    "llama-7b_fact": [
      "JGraphT is a library for the manipulation of graphs implemented in Java and C++.",
      "GraphBLAS is a library for the manipulation of graphs implemented in Java and C++.",
      "JKernel is a library for the implementation of graph kernels implemented in Java."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: JGraphT is a library for the manipulation of graphs implemented in Java.\n2. UNKNOWN\n3. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-7b_response": "The SHERLOCKv2 platform integrates four advances: 1) Natural Language Processing (NLP) for understanding the user's intent; 2) Natural Language Generation (NLG) for producing natural-sounding responses; 3) Machine Learning (ML) for adapting to the user's preferences; and 4) Knowledge Graphs (KG) for providing accurate and up-to-date information.",
    "llama-7b_fact_raw": "1. SHERLOCKv2 platform uses Natural Language Processing (NLP) for understanding user intent.\n2. SHERLOCKv2 platform incorporates Natural Language Generation (NLG) for generating responses.\n3. Machine Learning (ML) is integrated into SHERLOCKv2 platform for adapting to user preferences.\n4. Knowledge Graphs (KG) are utilized in SHERLOCKv2 platform to provide accurate information.",
    "llama-7b_fact": [
      "SHERLOCKv2 platform uses Natural Language Processing (NLP) for understanding user intent.",
      "SHERLOCKv2 platform incorporates Natural Language Generation (NLG) for generating responses.",
      "Machine Learning (ML) is integrated into SHERLOCKv2 platform for adapting to user preferences.",
      "Knowledge Graphs (KG) are utilized in SHERLOCKv2 platform to provide accurate information."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-7b_response": "The bartender algorithm is an algorithm used in natural language processing (NLP) to generate responses to user queries. It is based on the idea of a bartender who listens to a customer's query and responds with the most appropriate response. The algorithm works by first analyzing the user's query and then generating a list of potential responses. It then selects the most appropriate response based on the context of the query and the user's preferences. The response is then generated and presented to the user.",
    "llama-7b_fact_raw": "1. The bartender algorithm is used in natural language processing.\n2. It generates responses to user queries.\n3. The algorithm analyzes the user's query and generates a list of potential responses.\n4. It selects the most appropriate response based on the context of the query and the user's preferences.\n5. The selected response is presented to the user.",
    "llama-7b_fact": [
      "The bartender algorithm is used in natural language processing.",
      "It generates responses to user queries.",
      "The algorithm analyzes the user's query and generates a list of potential responses.",
      "It selects the most appropriate response based on the context of the query and the user's preferences.",
      "The selected response is presented to the user."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There is no known \"bartender algorithm\" used in natural language processing. \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-7b_response": "There are several web-based pedigree editors available, including Family Tree Builder, MyHeritage, Geni, and WeRelate. Family Tree Builder is a free, user-friendly program offered by Ancestry.com. MyHeritage is a paid service that offers a wide range of features, including the ability to collaborate with others on your family tree. Geni is a free, collaborative family tree that allows users to connect with their relatives and build their family tree. WeRelate is a free, open-source family tree that is maintained by the WeRelate community.",
    "llama-7b_fact_raw": "1. Family Tree Builder, MyHeritage, Geni, and WeRelate are web-based pedigree editors.\n2. Family Tree Builder is offered by Ancestry.com for free.\n3. MyHeritage is a paid service that includes collaborative features for family tree building.\n4. Geni allows users to connect with relatives and build a family tree collaboratively for free.\n5. WeRelate is an open-source, community-maintained free family tree editor.",
    "llama-7b_fact": [
      "Family Tree Builder, MyHeritage, Geni, and WeRelate are web-based pedigree editors.",
      "Family Tree Builder is offered by Ancestry.com for free.",
      "MyHeritage is a paid service that includes collaborative features for family tree building.",
      "Geni allows users to connect with relatives and build a family tree collaboratively for free.",
      "WeRelate is an open-source, community-maintained free family tree editor."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Family Tree Builder is offered by MyHeritage for free.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-7b_response": "There are several curated databases that exist for spider-venom toxins. These include the Spider Toxin Database (STD) (http://www.spidertoxins.com/), the World Spider Catalog (WSC) (http://wsc.nmbe.ch/), and the Arachnobase database (http://arachnobase.org/). All of these databases provide comprehensive information about spider-venom toxins, including their structures, activities, and biological effects.",
    "llama-7b_fact_raw": "1. The Spider Toxin Database (STD) is a curated database for spider-venom toxins.\n2. The World Spider Catalog (WSC) is another curated database for spider-venom toxins.\n3. The Arachnobase database is a curated database focusing on spider-venom toxins.\n4. These databases include information about the structures, activities, and biological effects of spider-venom toxins.",
    "llama-7b_fact": [
      "The Spider Toxin Database (STD) is a curated database for spider-venom toxins.",
      "The World Spider Catalog (WSC) is another curated database for spider-venom toxins.",
      "The Arachnobase database is a curated database focusing on spider-venom toxins.",
      "These databases include information about the structures, activities, and biological effects of spider-venom toxins."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The World Spider Catalog (WSC) is a curated database that provides taxonomic information about spider species, not specifically spider-venom toxins.\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-7b_response": "Axitinib, a tyrosine kinase inhibitor, has been shown to prolong survival in patients with metastatic pancreatic cancer in a randomized, double-blind, placebo-controlled phase III trial. In this trial, patients who received Axitinib had a median overall survival of 6.8 months compared to 4.7 months for those who received placebo. These results suggest that Axitinib may be an effective treatment for patients with metastatic pancreatic cancer.",
    "llama-7b_fact_raw": "1. Axitinib is a tyrosine kinase inhibitor.\n2. Axitinib has been shown to prolong survival in patients with metastatic pancreatic cancer.\n3. The evidence comes from a randomized, double-blind, placebo-controlled phase III trial.\n4. Patients who received Axitinib had a median overall survival of 6.8 months.\n5. Patients who received placebo had a median overall survival of 4.7 months.",
    "llama-7b_fact": [
      "Axitinib is a tyrosine kinase inhibitor.",
      "Axitinib has been shown to prolong survival in patients with metastatic pancreatic cancer.",
      "The evidence comes from a randomized, double-blind, placebo-controlled phase III trial.",
      "Patients who received Axitinib had a median overall survival of 6.8 months.",
      "Patients who received placebo had a median overall survival of 4.7 months."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Axitinib has been shown to prolong survival in patients with advanced renal cell carcinoma, not metastatic pancreatic cancer.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-7b_response": "MLP regulates F-actin dynamics through its interaction with the Arp2/3 complex. The Arp2/3 complex is a protein complex involved in the formation of branched actin filaments, which are essential for cell motility and morphology. MLP binds to the Arp2/3 complex and inhibits its activity, thus regulating F-actin dynamics.",
    "llama-7b_fact_raw": "1. MLP regulates F-actin dynamics through interaction with the Arp2/3 complex.\n2. The Arp2/3 complex is involved in the formation of branched actin filaments.\n3. Branched actin filaments are essential for cell motility and morphology.\n4. MLP binds to the Arp2/3 complex and inhibits its activity.",
    "llama-7b_fact": [
      "MLP regulates F-actin dynamics through interaction with the Arp2/3 complex.",
      "The Arp2/3 complex is involved in the formation of branched actin filaments.",
      "Branched actin filaments are essential for cell motility and morphology.",
      "MLP binds to the Arp2/3 complex and inhibits its activity."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: MLP binds to the Arp2/3 complex and activates its activity.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-7b_response": "There are 51 pseudokinases in the human kinome.",
    "llama-7b_fact_raw": "1. There are 51 pseudokinases in the human kinome.",
    "llama-7b_fact": [
      "There are 51 pseudokinases in the human kinome."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There are over 90 pseudokinases in the human kinome.",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-7b_response": "1. Apolipoprotein M (apoM)\n2. Apolipoprotein J (apoJ)\n3. Apolipoprotein S (apoS)",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-7b_response": "There are sex differences in SAMHD1 activity. In humans, SAMHD1 activity is higher in females than in males. This is due to the fact that females have two X chromosomes, while males only have one X chromosome and one Y chromosome. The X chromosome contains a gene that codes for the SAMHD1 protein, and the Y chromosome does not. Therefore, the amount of SAMHD1 protein produced is higher in females, who have two X chromosomes, than in males, who only have one X chromosome.",
    "llama-7b_fact_raw": "1. SAMHD1 activity is higher in females compared to males in humans.\n2. Females have two X chromosomes.\n3. Males have one X chromosome and one Y chromosome.\n4. The X chromosome contains a gene that codes for the SAMHD1 protein.\n5. The Y chromosome does not contain a gene that codes for the SAMHD1 protein.",
    "llama-7b_fact": [
      "SAMHD1 activity is higher in females compared to males in humans.",
      "Females have two X chromosomes.",
      "Males have one X chromosome and one Y chromosome.",
      "The X chromosome contains a gene that codes for the SAMHD1 protein.",
      "The Y chromosome does not contain a gene that codes for the SAMHD1 protein."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-7b_response": "RUNX2 is a transcription factor that has been shown to inhibit astrocyte differentiation in certain cell types. Studies have shown that RUNX2 can bind to the promoters of genes involved in astrocyte differentiation, such as the GFAP gene, and repress their expression. This leads to a decrease in the number of astrocytes in the cell population. Additionally, RUNX2 has been shown to interact with other transcription factors, such as SOX2, to further inhibit astrocyte differentiation.",
    "llama-7b_fact_raw": "1. RUNX2 is a transcription factor.\n2. RUNX2 inhibits astrocyte differentiation in certain cell types.\n3. Studies suggest that RUNX2 binds to the promoters of genes like the GFAP gene.\n4. RUNX2 represses the expression of genes involved in astrocyte differentiation.\n5. Interaction of RUNX2 with other transcription factors, such as SOX2, further inhibits astrocyte differentiation.",
    "llama-7b_fact": [
      "RUNX2 is a transcription factor.",
      "RUNX2 inhibits astrocyte differentiation in certain cell types.",
      "Studies suggest that RUNX2 binds to the promoters of genes like the GFAP gene.",
      "RUNX2 represses the expression of genes involved in astrocyte differentiation.",
      "Interaction of RUNX2 with other transcription factors, such as SOX2, further inhibits astrocyte differentiation."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-7b_response": "The Cobb-Stainsby excision arthroplasty would be performed on the distal end of the radius, near the wrist joint.",
    "llama-7b_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is performed on the distal end of the radius.\n2. The procedure takes place near the wrist joint.",
    "llama-7b_fact": [
      "The Cobb-Stainsby excision arthroplasty is performed on the distal end of the radius.",
      "The procedure takes place near the wrist joint."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is performed on the metatarsophalangeal joint of the foot.\n2. FALSE [correction]: The procedure takes place near the metatarsophalangeal joint, not the wrist joint.",
    "llama-7b_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-7b_response": "No, GRHL2 over-expression does not lead to EMT.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-7b_response": "T-UCRs that have been implicated in lung cancer include TP53, CDKN2A, RB1, and SMAD4. TP53 is the most frequently mutated gene in lung cancer and is involved in regulating cell growth and division. CDKN2A is a tumor suppressor gene that is often inactivated in lung cancer and other cancers. RB1 is a gene that encodes a protein that is important for cell growth and division, and mutations in this gene can lead to lung cancer. Lastly, SMAD4 is a gene that is involved in the tumor suppressor pathway and mutations in this gene can lead to the development of lung cancer.",
    "llama-7b_fact_raw": "1. TP53, CDKN2A, RB1, and SMAD4 are T-UCRs implicated in lung cancer.\n2. TP53 is the most frequently mutated gene in lung cancer.\n3. TP53 is involved in regulating cell growth and division.\n4. CDKN2A is a tumor suppressor gene often inactivated in lung cancer.\n5. Mutations in the gene SMAD4 can lead to the development of lung cancer.",
    "llama-7b_fact": [
      "TP53, CDKN2A, RB1, and SMAD4 are T-UCRs implicated in lung cancer.",
      "TP53 is the most frequently mutated gene in lung cancer.",
      "TP53 is involved in regulating cell growth and division.",
      "CDKN2A is a tumor suppressor gene often inactivated in lung cancer.",
      "Mutations in the gene SMAD4 can lead to the development of lung cancer."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-7b_response": "GPR151 is an orphan receptor that is highly expressed in the brain, particularly in the hippocampus and cerebellum. It is also expressed in the heart, kidney, and placenta. GPR151 is known to be a G-protein-coupled receptor, meaning it interacts with and is activated by signaling molecules known as G-proteins. Studies have shown that GPR151 is involved in the regulation of cell growth and metabolism, as well as in the modulation of inflammatory and immune responses. Additionally, GPR151 has been linked to the development of certain neurological disorders, such as Alzheimer's and Parkinson's diseases.",
    "llama-7b_fact_raw": "1. GPR151 is an orphan receptor with high expression in the brain.\n2. The hippocampus and cerebellum are areas of the brain where GPR151 is highly expressed.\n3. GPR151 is also expressed in the heart, kidney, and placenta.\n4. GPR151 is a G-protein-coupled receptor that interacts with G-proteins.\n5. GPR151 has been linked to the development of neurological disorders like Alzheimer's and Parkinson's diseases.",
    "llama-7b_fact": [
      "GPR151 is an orphan receptor with high expression in the brain.",
      "The hippocampus and cerebellum are areas of the brain where GPR151 is highly expressed.",
      "GPR151 is also expressed in the heart, kidney, and placenta.",
      "GPR151 is a G-protein-coupled receptor that interacts with G-proteins.",
      "GPR151 has been linked to the development of neurological disorders like Alzheimer's and Parkinson's diseases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: GPR151 is not expressed in the heart, kidney, and placenta, but rather is primarily expressed in the central nervous system.\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-7b_response": "The Fluzone intradermal quadrivalent vaccine contains attenuated live virus strains of influenza A (H1N1), influenza A (H3N2), influenza B (Victoria lineage) and influenza B (Yamagata lineage).",
    "llama-7b_fact_raw": "1. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H1N1).\n2. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H3N2).\n3. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Victoria lineage).\n4. The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Yamagata lineage).",
    "llama-7b_fact": [
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H1N1).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza A (H3N2).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Victoria lineage).",
      "The Fluzone intradermal quadrivalent vaccine contains an attenuated live virus strain of influenza B (Yamagata lineage)."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine does not contain a live virus, it contains an inactivated virus.\n2. FALSE [correction]: The Fluzone intradermal quadrivalent vaccine contains an inactivated virus strain of influenza A (H3N2).\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-7b_response": "The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE) due to a genetic variation in the promoter region of the gene. This variation results in decreased expression of the TNFR2 protein, which is believed to play a role in the development of SLE.",
    "llama-7b_fact_raw": "1. The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE).\n2. The genetic variation associated with SLE in the TNFR2 gene is located in the promoter region.\n3. This genetic variation results in decreased expression of the TNFR2 protein.",
    "llama-7b_fact": [
      "The TNFR2 gene is associated with Systemic Lupus Erythematosus (SLE).",
      "The genetic variation associated with SLE in the TNFR2 gene is located in the promoter region.",
      "This genetic variation results in decreased expression of the TNFR2 protein."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-7b_response": "Yes, there is a vaccine for peanut allergy. The vaccine, called Palforzia, was approved by the FDA in 2020. It is designed to reduce the risk of a severe allergic reaction to peanuts if the person is exposed to them. The vaccine is administered in two doses, six months apart, and can be given to children aged 4 to 17 who have a severe peanut allergy.",
    "llama-7b_fact_raw": "1. Palforzia is a vaccine for peanut allergy.\n2. The FDA approved Palforzia in 2020.\n3. Palforzia is designed to reduce the risk of a severe allergic reaction to peanuts.\n4. The vaccine is administered in two doses, six months apart.\n5. Palforzia can be given to children aged 4 to 17 who have a severe peanut allergy.",
    "llama-7b_fact": [
      "Palforzia is a vaccine for peanut allergy.",
      "The FDA approved Palforzia in 2020.",
      "Palforzia is designed to reduce the risk of a severe allergic reaction to peanuts.",
      "The vaccine is administered in two doses, six months apart.",
      "Palforzia can be given to children aged 4 to 17 who have a severe peanut allergy."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Palforzia is not a vaccine, it is an oral immunotherapy treatment for peanut allergy.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Palforzia is not administered as a vaccine in doses, it is taken daily as an oral treatment.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-7b_response": "The mouse Fxy gene is located on the X chromosome, which is one of the two sex chromosomes in mammals. It is particular in that it is one of the few genes located on the X chromosome that is not involved in determining sex. Instead, it is involved in the development of the embryo and is expressed in both males and females.",
    "llama-7b_fact_raw": "1. The mouse Fxy gene is located on the X chromosome.\n2. The X chromosome is one of the two sex chromosomes in mammals.\n3. The Fxy gene is not involved in determining sex.\n4. The Fxy gene is involved in the development of the embryo.\n5. The Fxy gene is expressed in both male and female mice.",
    "llama-7b_fact": [
      "The mouse Fxy gene is located on the X chromosome.",
      "The X chromosome is one of the two sex chromosomes in mammals.",
      "The Fxy gene is not involved in determining sex.",
      "The Fxy gene is involved in the development of the embryo.",
      "The Fxy gene is expressed in both male and female mice."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-7b_response": "The MPE-seq method is based on the principle of selective enrichment of methylated DNA. It uses methyl-propyl-EDTA (MPE) to bind to methylated DNA, allowing for the enrichment of methylated DNA from a genomic DNA sample. The MPE-seq method then uses next-generation sequencing (NGS) to sequence the methylated DNA and identify regions of methylation.",
    "llama-7b_fact_raw": "1. MPE-seq method uses selective enrichment of methylated DNA as its basis.\n2. Methyl-propyl-EDTA (MPE) binds to methylated DNA in the MPE-seq method.\n3. The MPE-seq method enriches methylated DNA from genomic DNA samples.\n4. Next-generation sequencing (NGS) is utilized in the MPE-seq method to sequence methylated DNA.\n5. MPE-seq method identifies regions of methylation in DNA.",
    "llama-7b_fact": [
      "MPE-seq method uses selective enrichment of methylated DNA as its basis.",
      "Methyl-propyl-EDTA (MPE) binds to methylated DNA in the MPE-seq method.",
      "The MPE-seq method enriches methylated DNA from genomic DNA samples.",
      "Next-generation sequencing (NGS) is utilized in the MPE-seq method to sequence methylated DNA.",
      "MPE-seq method identifies regions of methylation in DNA."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Methyl-CpG binding domain protein (MBD) is used to bind to methylated DNA in the MPE-seq method, not Methyl-propyl-EDTA (MPE).\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-7b_response": "GWAR has been implemented using the Python programming language.",
    "llama-7b_fact_raw": "1. GWAR was implemented using the Python programming language.",
    "llama-7b_fact": [
      "GWAR was implemented using the Python programming language."
    ],
    "llama-7b_judge_raw": "UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-7b_response": "Xaliproden has been shown to have a positive effect on the prognosis of amyotrophic lateral sclerosis (ALS) in some studies, while others have shown no effect. ALS is a progressive neurodegenerative disease with no known cure, so any potential treatment is of great interest. Xaliproden has been shown to reduce inflammation, which may be beneficial in ALS, as inflammation has been linked to the progression of the disease. Additionally, it has been suggested that xaliproden may help to protect motor neurons, which could improve the prognosis of ALS. However, more research is needed to confirm these findings.",
    "llama-7b_fact_raw": "1. Some studies have shown that Xaliproden has a positive effect on the prognosis of amyotrophic lateral sclerosis (ALS).\n2. Other studies have shown that Xaliproden has no effect on the prognosis of ALS.\n3. ALS is a progressive neurodegenerative disease with no known cure.\n4. Xaliproden has been shown to reduce inflammation.\n5. It has been suggested that Xaliproden may help to protect motor neurons.",
    "llama-7b_fact": [
      "Some studies have shown that Xaliproden has a positive effect on the prognosis of amyotrophic lateral sclerosis (ALS).",
      "Other studies have shown that Xaliproden has no effect on the prognosis of ALS.",
      "ALS is a progressive neurodegenerative disease with no known cure.",
      "Xaliproden has been shown to reduce inflammation.",
      "It has been suggested that Xaliproden may help to protect motor neurons."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-7b_response": "Transgenes are inserted in the LiPS-A3S line in the X chromosome.",
    "llama-7b_fact_raw": "1. In the LiPS-A3S line, transgenes are inserted into the X chromosome.",
    "llama-7b_fact": [
      "In the LiPS-A3S line, transgenes are inserted into the X chromosome."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-7b_response": "A tool for predicting drug synergy with deep learning exists in the form of SynergyNet. SynergyNet is a deep learning model that uses a combination of convolutional and recurrent neural networks to predict the synergy of drug combinations. The model is trained on a large dataset of drug combinations and is able to accurately predict the synergy of drug combinations.",
    "llama-7b_fact_raw": "1. SynergyNet is a tool for predicting drug synergy using deep learning.\n2. SynergyNet utilizes both convolutional and recurrent neural networks in its model.\n3. The model is trained on a dataset of drug combinations. \n4. SynergyNet can accurately predict the synergy of drug combinations.",
    "llama-7b_fact": [
      "SynergyNet is a tool for predicting drug synergy using deep learning.",
      "SynergyNet utilizes both convolutional and recurrent neural networks in its model.",
      "The model is trained on a dataset of drug combinations.",
      "SynergyNet can accurately predict the synergy of drug combinations."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-7b_response": "The Genome-Wide Association Study (GWAS) Comparison Platform (GCP) has been developed for comparing GWAS. It is a cloud-based platform that allows researchers to store, analyze, and compare GWAS data from multiple sources in a secure and efficient manner. GCP provides a suite of tools to facilitate the comparison of GWAS data, including data visualization, statistical analysis, and machine learning algorithms.",
    "llama-7b_fact_raw": "1. The Genome-Wide Association Study (GWAS) Comparison Platform (GCP) is developed for comparing GWAS.\n2. GCP is a cloud-based platform.\n3. The platform allows researchers to store, analyze, and compare GWAS data from multiple sources.\n4. GCP provides tools for data visualization, statistical analysis, and machine learning algorithms.",
    "llama-7b_fact": [
      "The Genome-Wide Association Study (GWAS) Comparison Platform (GCP) is developed for comparing GWAS.",
      "GCP is a cloud-based platform.",
      "The platform allows researchers to store, analyze, and compare GWAS data from multiple sources.",
      "GCP provides tools for data visualization, statistical analysis, and machine learning algorithms."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-7b_response": "CMB305 has been shown to be effective against certain types of sarcomas in preclinical studies. However, its efficacy against sarcomas has not yet been tested in clinical trials. Therefore, it is not yet known if CMB305 is an effective treatment for sarcomas.",
    "llama-7b_fact_raw": "1. CMB305 has been effective against certain types of sarcomas in preclinical studies.\n2. CMB305 has not been tested in clinical trials for its efficacy against sarcomas.",
    "llama-7b_fact": [
      "CMB305 has been effective against certain types of sarcomas in preclinical studies.",
      "CMB305 has not been tested in clinical trials for its efficacy against sarcomas."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: CMB305 has been tested in clinical trials for its efficacy against sarcomas.",
    "llama-7b_judge": [
      "unknown",
      "false"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-7b_response": "The manifestations of the Saint's Triad refer to the three main aspects of a saint's life: holiness, miracles, and intercession. Holiness refers to a saint's personal piety and devotion to God, while miracles refer to the extraordinary events that are attributed to a saint's power and intercession refers to the saint's ability to intervene on behalf of those who pray to them.",
    "llama-7b_fact_raw": "1. The Saint's Triad consists of holiness, miracles, and intercession.\n2. Holiness in the context of the Saint's Triad refers to a saint's personal piety and devotion to God.\n3. Miracles in the Saint's Triad refer to extraordinary events attributed to a saint's power.\n4. Intercession in the Saint's Triad refers to a saint's ability to intervene on behalf of those who pray to them.",
    "llama-7b_fact": [
      "The Saint's Triad consists of holiness, miracles, and intercession.",
      "Holiness in the context of the Saint's Triad refers to a saint's personal piety and devotion to God.",
      "Miracles in the Saint's Triad refer to extraordinary events attributed to a saint's power.",
      "Intercession in the Saint's Triad refers to a saint's ability to intervene on behalf of those who pray to them."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-7b_response": "Overexpression of LY6K has been found to be associated with better prognosis for non-small cell lung cancer patients in some studies, while others have found no correlation between LY6K expression and patient survival. The results are inconclusive and further research is needed to determine the exact role of LY6K in non-small cell lung cancer prognosis.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-7b_response": "The Cdk targets that are dephosphorylated during cytokinesis include cyclin B, Cdc14, and Plk1. Cyclin B is dephosphorylated by the Cdc14 phosphatase, which is activated at the metaphase-to-anaphase transition. Cdc14 is also responsible for dephosphorylating Cdk1, which is necessary for the completion of cytokinesis. Finally, Plk1 is dephosphorylated by the Cdc14 phosphatase, allowing it to no longer bind to the mitotic spindle and allowing the completion of cytokinesis.",
    "llama-7b_fact_raw": "1. Cyclin B, Cdc14, and Plk1 are Cdk targets that are dephosphorylated during cytokinesis.\n2. Cyclin B is dephosphorylated by the Cdc14 phosphatase.\n3. The Cdc14 phosphatase is activated at the metaphase-to-anaphase transition.\n4. Cdc14 is responsible for dephosphorylating Cdk1, which is necessary for cytokinesis completion.\n5. Plk1 is dephosphorylated by the Cdc14 phosphatase, enabling it to detach from the mitotic spindle.",
    "llama-7b_fact": [
      "Cyclin B, Cdc14, and Plk1 are Cdk targets that are dephosphorylated during cytokinesis.",
      "Cyclin B is dephosphorylated by the Cdc14 phosphatase.",
      "The Cdc14 phosphatase is activated at the metaphase-to-anaphase transition.",
      "Cdc14 is responsible for dephosphorylating Cdk1, which is necessary for cytokinesis completion.",
      "Plk1 is dephosphorylated by the Cdc14 phosphatase, enabling it to detach from the mitotic spindle."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Cyclin B, Cdc14, and Plk1 are not Cdk targets but rather proteins that regulate the cell cycle during cytokinesis.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Cdc14 is responsible for dephosphorylating substrates of Cdk1, not Cdk1 itself, which is necessary for cytokinesis completion.\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-7b_response": "Xanamem is a novel, investigational medicine being studied for the treatment of mild to moderate Alzheimer's disease. It is an orally administered small molecule that has been shown in clinical trials to have a positive effect on cognition and function in patients with Alzheimer's disease. Xanamem works by increasing the levels of the neurotransmitter acetylcholine in the brain, which is decreased in Alzheimer's disease.",
    "llama-7b_fact_raw": "1. Xanamem is an investigational medicine being studied for the treatment of mild to moderate Alzheimer's disease.\n2. Xanamem is orally administered.\n3. Clinical trials have shown a positive effect on cognition and function in patients with Alzheimer's disease.\n4. Xanamem works by increasing the levels of the neurotransmitter acetylcholine in the brain.\n5. Acetylcholine levels are decreased in Alzheimer's disease.",
    "llama-7b_fact": [
      "Xanamem is an investigational medicine being studied for the treatment of mild to moderate Alzheimer's disease.",
      "Xanamem is orally administered.",
      "Clinical trials have shown a positive effect on cognition and function in patients with Alzheimer's disease.",
      "Xanamem works by increasing the levels of the neurotransmitter acetylcholine in the brain.",
      "Acetylcholine levels are decreased in Alzheimer's disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: Xanamem works by blocking the production of excess cortisol in the brain, not by increasing acetylcholine levels.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-7b_response": "The Hof1-Cyk3 interaction is important for the proper functioning of the cell cycle in yeast. Cyk3 is a cyclin-dependent kinase and Hof1 is a protein that binds to and activates Cyk3. The interaction between Hof1 and Cyk3 is necessary for the activation of Cyk3 and the progression of the cell cycle. Without the Hof1-Cyk3 interaction, the cell cycle would be disrupted and the cell would not be able to divide properly.",
    "llama-7b_fact_raw": "1. The Hof1-Cyk3 interaction is important for the cell cycle in yeast.\n2. Cyk3 is a cyclin-dependent kinase.\n3. Hof1 is a protein that binds to and activates Cyk3.\n4. The interaction between Hof1 and Cyk3 activates Cyk3.\n5. Without the Hof1-Cyk3 interaction, the yeast cell cycle would be disrupted and the cell would not divide properly.",
    "llama-7b_fact": [
      "The Hof1-Cyk3 interaction is important for the cell cycle in yeast.",
      "Cyk3 is a cyclin-dependent kinase.",
      "Hof1 is a protein that binds to and activates Cyk3.",
      "The interaction between Hof1 and Cyk3 activates Cyk3.",
      "Without the Hof1-Cyk3 interaction, the yeast cell cycle would be disrupted and the cell would not divide properly."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cyk3 is a transglycosylase, not a cyclin-dependent kinase.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-7b_response": "T-UCRs that have been implicated in gastric cancer include T-UCR-1, T-UCR-2, T-UCR-3, T-UCR-4, T-UCR-5, T-UCR-6, T-UCR-7, T-UCR-8, T-UCR-9, and T-UCR-10.",
    "llama-7b_fact_raw": "1. T-UCR-1 has been implicated in gastric cancer.\n2. T-UCR-2 has been implicated in gastric cancer.\n3. T-UCR-3 has been implicated in gastric cancer.\n4. T-UCR-4 has been implicated in gastric cancer.\n5. T-UCR-5 has been implicated in gastric cancer.",
    "llama-7b_fact": [
      "T-UCR-1 has been implicated in gastric cancer.",
      "T-UCR-2 has been implicated in gastric cancer.",
      "T-UCR-3 has been implicated in gastric cancer.",
      "T-UCR-4 has been implicated in gastric cancer.",
      "T-UCR-5 has been implicated in gastric cancer."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout further context or information about T-UCR-1 to T-UCR-5 and their relation to gastric cancer, it is impossible to determine the truthfulness of these statements.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-7b_response": "The Lupus Severity Index (LSI) is a tool used to measure the severity of systemic lupus erythematosus (SLE) in patients. It was developed by the National Institutes of Health (NIH) in 1992 and is based on a combination of clinical and laboratory criteria. The LSI takes into account the patient's overall health, the number and severity of organ involvements, and the presence of disease flares. A higher score on the LSI indicates a more severe form of lupus.",
    "llama-7b_fact_raw": "1. The Lupus Severity Index (LSI) measures the severity of systemic lupus erythematosus (SLE) in patients.\n2. The National Institutes of Health (NIH) developed the LSI in 1992.\n3. The LSI is based on clinical and laboratory criteria.\n4. The LSI considers the patient's overall health, organ involvements, and disease flares.\n5. A higher score on the LSI indicates a more severe form of lupus.",
    "llama-7b_fact": [
      "The Lupus Severity Index (LSI) measures the severity of systemic lupus erythematosus (SLE) in patients.",
      "The National Institutes of Health (NIH) developed the LSI in 1992.",
      "The LSI is based on clinical and laboratory criteria.",
      "The LSI considers the patient's overall health, organ involvements, and disease flares.",
      "A higher score on the LSI indicates a more severe form of lupus."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was developed by the National Institutes of Health (NIH) in 1985, not the Lupus Severity Index (LSI).\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-7b_response": "De novo mutations in ZSWIM6 have been linked to the development of certain genetic disorders, including autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), Friedreich's ataxia (FRDA), and spinocerebellar ataxia type 6 (SCA6). ARSACS is a neurodegenerative disorder characterized by progressive spasticity and ataxia. FRDA is an autosomal recessive disorder that causes progressive damage to the heart, liver, and other organs. SCA6 is an autosomal dominant ataxia that results in progressive loss of coordination and balance.",
    "llama-7b_fact_raw": "1. De novo mutations in ZSWIM6 are linked to the development of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).\n2. De novo mutations in ZSWIM6 are linked to the development of Friedreich's ataxia (FRDA).\n3. De novo mutations in ZSWIM6 are linked to the development of spinocerebellar ataxia type 6 (SCA6).\n4. ARSACS is characterized by progressive spasticity and ataxia.\n5. FRDA causes progressive damage to the heart, liver, and other organs.",
    "llama-7b_fact": [
      "De novo mutations in ZSWIM6 are linked to the development of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).",
      "De novo mutations in ZSWIM6 are linked to the development of Friedreich's ataxia (FRDA).",
      "De novo mutations in ZSWIM6 are linked to the development of spinocerebellar ataxia type 6 (SCA6).",
      "ARSACS is characterized by progressive spasticity and ataxia.",
      "FRDA causes progressive damage to the heart, liver, and other organs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Mutations in the SACS gene, not ZSWIM6, are linked to the development of autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. FALSE [correction]: FRDA primarily causes progressive damage to the nervous system and the heart, not the liver and other organs.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "true",
      "false"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-7b_response": "The Koos Classification is used to classify infective endocarditis, which is an inflammation of the lining of the heart caused by bacterial infection.",
    "llama-7b_fact_raw": "1. The Koos Classification is used for classifying infective endocarditis.\n2. Infective endocarditis is an inflammation of the lining of the heart.\n3. Infective endocarditis is caused by bacterial infection.",
    "llama-7b_fact": [
      "The Koos Classification is used for classifying infective endocarditis.",
      "Infective endocarditis is an inflammation of the lining of the heart.",
      "Infective endocarditis is caused by bacterial infection."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Duke Criteria is used for classifying infective endocarditis.\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-7b_response": "AZD8601 is a potent and selective inhibitor of the c-Met receptor tyrosine kinase, which is over-expressed in many types of cancer. In vivo studies have shown that AZD8601 can reduce tumor growth and metastasis in mouse models of cancer, as well as reduce the number of circulating tumor cells in patients with metastatic cancer. Additionally, AZD8601 has been shown to improve overall survival and progression-free survival in patients with advanced cancer.",
    "llama-7b_fact_raw": "1. AZD8601 is a potent and selective inhibitor of the c-Met receptor tyrosine kinase.\n2. The c-Met receptor tyrosine kinase is over-expressed in many types of cancer.\n3. In vivo studies show AZD8601 can reduce tumor growth and metastasis in mouse models of cancer.\n4. AZD8601 can reduce the number of circulating tumor cells in patients with metastatic cancer.\n5. AZD8601 has been shown to improve overall survival and progression-free survival in patients with advanced cancer.",
    "llama-7b_fact": [
      "AZD8601 is a potent and selective inhibitor of the c-Met receptor tyrosine kinase.",
      "The c-Met receptor tyrosine kinase is over-expressed in many types of cancer.",
      "In vivo studies show AZD8601 can reduce tumor growth and metastasis in mouse models of cancer.",
      "AZD8601 can reduce the number of circulating tumor cells in patients with metastatic cancer.",
      "AZD8601 has been shown to improve overall survival and progression-free survival in patients with advanced cancer."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-7b_response": "SAHFS are created through a process called synthesis, which involves the combination of two or more molecules to form a new compound with different properties. The molecules used in synthesis can be organic compounds, inorganic compounds, or other molecules containing carbon. During synthesis, the molecules are typically heated in the presence of a catalyst, which helps to speed up the reaction and increase the yield of the desired product.",
    "llama-7b_fact_raw": "1. SAHFS are created through a process called synthesis.\n2. Synthesis involves combining two or more molecules to form a new compound.\n3. The molecules used in synthesis can be organic, inorganic, or contain carbon.\n4. During synthesis, the molecules are typically heated in the presence of a catalyst.\n5. Catalysts are used to speed up the reaction and increase the yield of the product.",
    "llama-7b_fact": [
      "SAHFS are created through a process called synthesis.",
      "Synthesis involves combining two or more molecules to form a new compound.",
      "The molecules used in synthesis can be organic, inorganic, or contain carbon.",
      "During synthesis, the molecules are typically heated in the presence of a catalyst.",
      "Catalysts are used to speed up the reaction and increase the yield of the product."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-7b_response": "The PDZ domain of SATB1 is a protein-protein interaction domain that binds to the PDZ domains of other proteins. This interaction is important for the formation of the SATB1 protein complex, which is involved in the transcriptional regulation of genes involved in cell growth and development.",
    "llama-7b_fact_raw": "1. The PDZ domain of SATB1 is a protein-protein interaction domain.\n2. SATB1's PDZ domain binds to the PDZ domains of other proteins.\n3. The interaction of SATB1's PDZ domain is important for the formation of the SATB1 protein complex.\n4. The SATB1 protein complex is involved in the transcriptional regulation of genes.\n5. The genes regulated by the SATB1 protein complex are involved in cell growth and development.",
    "llama-7b_fact": [
      "The PDZ domain of SATB1 is a protein-protein interaction domain.",
      "SATB1's PDZ domain binds to the PDZ domains of other proteins.",
      "The interaction of SATB1's PDZ domain is important for the formation of the SATB1 protein complex.",
      "The SATB1 protein complex is involved in the transcriptional regulation of genes.",
      "The genes regulated by the SATB1 protein complex are involved in cell growth and development."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: SATB1's PDZ domain does not bind to the PDZ domains of other proteins; it binds to PDZ-binding motifs at the C-termini of its target proteins.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-7b_response": "The BLISS technique is based on the principles of behaviorism, which states that behavior can be modified through the use of positive and negative reinforcement. The BLISS technique uses positive reinforcement to encourage desired behaviors and negative reinforcement to discourage undesired behaviors. Positive reinforcement can come in the form of praise, rewards, or other forms of recognition, while negative reinforcement can take the form of timeouts, removal of privileges, or other forms of punishment.",
    "llama-7b_fact_raw": "1. The BLISS technique is based on the principles of behaviorism.\n2. Behaviorism states that behavior can be modified through positive and negative reinforcement.\n3. The BLISS technique uses positive reinforcement to encourage desired behaviors.\n4. The BLISS technique uses negative reinforcement to discourage undesired behaviors.\n5. Forms of positive reinforcement used in the BLISS technique include praise, rewards, or recognition.",
    "llama-7b_fact": [
      "The BLISS technique is based on the principles of behaviorism.",
      "Behaviorism states that behavior can be modified through positive and negative reinforcement.",
      "The BLISS technique uses positive reinforcement to encourage desired behaviors.",
      "The BLISS technique uses negative reinforcement to discourage undesired behaviors.",
      "Forms of positive reinforcement used in the BLISS technique include praise, rewards, or recognition."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The BLISS technique does not use negative reinforcement; it focuses solely on positive reinforcement.\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-7b_response": "Three NK3R antagonists are aprepitant, fosaprepitant, and rolapitant.",
    "llama-7b_fact_raw": "1. Aprepitant is an NK3R antagonist.\n2. Fosaprepitant is an NK3R antagonist.\n3. Rolapitant is an NK3R antagonist.",
    "llama-7b_fact": [
      "Aprepitant is an NK3R antagonist.",
      "Fosaprepitant is an NK3R antagonist.",
      "Rolapitant is an NK3R antagonist."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Aprepitant is an NK1 receptor antagonist.\n2. FALSE [correction]: Fosaprepitant is a prodrug of aprepitant and therefore an NK1 receptor antagonist.\n3. FALSE [correction]: Rolapitant is an NK1 receptor antagonist.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-7b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is known as dapagliflozin. It was developed by Bristol-Myers Squibb and was approved by the FDA in 2014 for the treatment of type 2 diabetes.",
    "llama-7b_fact_raw": "1. Dapagliflozin is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.\n2. Bristol-Myers Squibb developed dapagliflozin.\n3. The FDA approved dapagliflozin in 2014 for the treatment of type 2 diabetes.",
    "llama-7b_fact": [
      "Dapagliflozin is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
      "Bristol-Myers Squibb developed dapagliflozin.",
      "The FDA approved dapagliflozin in 2014 for the treatment of type 2 diabetes."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Dapagliflozin is not a ghrelin receptor inverse agonist, it is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-7b_response": "The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be approximately 86%. This means that if 100 people receive the vaccine, approximately 86 of them will be protected against the disease.",
    "llama-7b_fact_raw": "1. The protective efficacy of Vaxchora against moderate to severe cholera is approximately 86%.",
    "llama-7b_fact": [
      "The protective efficacy of Vaxchora against moderate to severe cholera is approximately 86%."
    ],
    "llama-7b_judge_raw": "1. TRUE",
    "llama-7b_judge": [
      "true"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-7b_response": "The first cholera vaccine to be approved in the United States was Dukoral, which was approved in 2014. Dukoral is a live attenuated vaccine that is administered orally and is approved for use in adults and children aged two years and older. It is approved for the prevention of cholera caused by Vibrio cholerae serogroups O1 and O139.",
    "llama-7b_fact_raw": "1. Dukoral was the first cholera vaccine to be approved in the United States.\n2. Dukoral was approved in 2014.\n3. Dukoral is a live attenuated vaccine.\n4. Dukoral is administered orally.\n5. Dukoral is approved for use in adults and children aged two years and older.",
    "llama-7b_fact": [
      "Dukoral was the first cholera vaccine to be approved in the United States.",
      "Dukoral was approved in 2014.",
      "Dukoral is a live attenuated vaccine.",
      "Dukoral is administered orally.",
      "Dukoral is approved for use in adults and children aged two years and older."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Dukoral was not the first cholera vaccine to be approved in the United States; Vaxchora was the first, approved in 2016.\n2. FALSE [correction]: Dukoral was approved in 2003 by the World Health Organization, not specifically in the United States in 2014.\n3. FALSE [correction]: Dukoral is not a live attenuated vaccine, it is an inactivated vaccine.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is adenosine deaminase deficiency (ADA-SCID). ADA-SCID is caused by mutations in the ADA gene, which codes for the enzyme adenosine deaminase. This enzyme is essential for the normal development and function of B and T cells, which are key components of the immune system. As a result, individuals with ADA-SCID have severely compromised immune systems and are vulnerable to a wide range of infections.",
    "llama-7b_fact_raw": "1. Adenosine deaminase deficiency (ADA-SCID) is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. ADA-SCID is caused by mutations in the ADA gene.\n3. The ADA gene codes for the enzyme adenosine deaminase.\n4. Adenosine deaminase is essential for the normal development and function of B and T cells.\n5. Individuals with ADA-SCID have severely compromised immune systems.",
    "llama-7b_fact": [
      "Adenosine deaminase deficiency (ADA-SCID) is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "ADA-SCID is caused by mutations in the ADA gene.",
      "The ADA gene codes for the enzyme adenosine deaminase.",
      "Adenosine deaminase is essential for the normal development and function of B and T cells.",
      "Individuals with ADA-SCID have severely compromised immune systems."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Adenosine deaminase deficiency (ADA-SCID) is a cause of severe combined immunodeficiency (SCID), not common variable immunodeficiency (CVID).\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-7b_response": "The IFIT1 gene plays a role in the development of Systemic Lupus Erythematosus (SLE) by regulating the production of interferon-alpha. Interferon-alpha is an important antiviral and antiproliferative cytokine that helps to regulate the immune system and is important in the pathogenesis of SLE. Mutations in the IFIT1 gene have been linked to an increased risk of developing SLE.",
    "llama-7b_fact_raw": "1. The IFIT1 gene regulates the production of interferon-alpha.\n2. Interferon-alpha is an antiviral and antiproliferative cytokine.\n3. Interferon-alpha helps to regulate the immune system.\n4. Interferon-alpha is important in the pathogenesis of Systemic Lupus Erythematosus (SLE).\n5. Mutations in the IFIT1 gene have been linked to an increased risk of developing SLE.",
    "llama-7b_fact": [
      "The IFIT1 gene regulates the production of interferon-alpha.",
      "Interferon-alpha is an antiviral and antiproliferative cytokine.",
      "Interferon-alpha helps to regulate the immune system.",
      "Interferon-alpha is important in the pathogenesis of Systemic Lupus Erythematosus (SLE).",
      "Mutations in the IFIT1 gene have been linked to an increased risk of developing SLE."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The IFIT1 gene regulates the production of interferon-induced protein with tetratricopeptide repeats 1, not interferon-alpha.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-7b_response": "The Liverpool Elbow Score is a diagnostic tool used to assess the severity of an elbow injury. It is based on the patient's symptoms and physical examination findings, and provides a quick and easy way to assess the likelihood of a fracture or other serious injury. A high score indicates a greater likelihood of a fracture or other serious injury, while a low score indicates a less serious injury.",
    "llama-7b_fact_raw": "1. The Liverpool Elbow Score is used to assess the severity of an elbow injury.\n2. The score is based on the patient's symptoms and physical examination findings.\n3. A high Liverpool Elbow Score indicates a greater likelihood of a fracture or other serious injury.\n4. A low Liverpool Elbow Score indicates a less serious injury.",
    "llama-7b_fact": [
      "The Liverpool Elbow Score is used to assess the severity of an elbow injury.",
      "The score is based on the patient's symptoms and physical examination findings.",
      "A high Liverpool Elbow Score indicates a greater likelihood of a fracture or other serious injury.",
      "A low Liverpool Elbow Score indicates a less serious injury."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: A high Liverpool Elbow Score indicates a greater impact on the patient's elbow function and symptoms.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-7b_response": "The 100,000 Genomes Project is a UK-based project that aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases. As part of the project, researchers have been studying sarcoma, a type of cancer that affects the soft tissues and bones. Through the project, researchers have been able to identify new genetic variants associated with sarcoma, which can help inform diagnosis and treatment decisions. Additionally, the project has enabled researchers to develop a better understanding of the genetic basis of the disease and to identify potential targets for new therapies.",
    "llama-7b_fact_raw": "1. The 100,000 Genomes Project is a UK-based initiative.\n2. The project aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.\n3. Researchers within the project have been studying sarcoma.\n4. The 100,000 Genomes Project has identified new genetic variants associated with sarcoma.\n5. The project has contributed to a better understanding of the genetic basis of sarcoma and potential targets for new therapies.",
    "llama-7b_fact": [
      "The 100,000 Genomes Project is a UK-based initiative.",
      "The project aims to sequence 100,000 whole genomes from NHS patients with cancer and rare diseases.",
      "Researchers within the project have been studying sarcoma.",
      "The 100,000 Genomes Project has identified new genetic variants associated with sarcoma.",
      "The project has contributed to a better understanding of the genetic basis of sarcoma and potential targets for new therapies."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-7b_response": "Yes, protein ALEX1 contains armadillo repeats. It is a member of the Armadillo family of proteins, which are characterized by the presence of repetitive structures called armadillo repeats. These repeats are composed of approximately 60 amino acids and are found in the C-terminal region of ALEX1.",
    "llama-7b_fact_raw": "1. Protein ALEX1 contains armadillo repeats.\n2. ALEX1 is a member of the Armadillo family of proteins.\n3. Armadillo repeats are composed of approximately 60 amino acids.\n4. Armadillo repeats are found in the C-terminal region of ALEX1.",
    "llama-7b_fact": [
      "Protein ALEX1 contains armadillo repeats.",
      "ALEX1 is a member of the Armadillo family of proteins.",
      "Armadillo repeats are composed of approximately 60 amino acids.",
      "Armadillo repeats are found in the C-terminal region of ALEX1."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: ALEX1 is not a member of the Armadillo family of proteins; it is associated with the armadillo repeat containing protein family but is a distinct entity.\n3. TRUE\n4. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-7b_response": "Enzymes that remove histone modifications include histone deacetylases (HDACs), histone methyltransferases (HMTs), and histone demethylases (HDMLs).",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-7b_response": "The evidence suggests that head CT scans may increase the risk of developing a brain tumor. Studies have shown that repeated exposure to radiation from CT scans can cause changes in the cells of the brain, which can lead to the development of a tumor. Additionally, CT scans can cause inflammation in the brain, which can also increase the risk of developing a tumor. For these reasons, it is recommended that CT scans be used only when absolutely necessary.",
    "llama-7b_fact_raw": "1. Head CT scans may increase the risk of developing a brain tumor.\n2. Repeated exposure to radiation from CT scans can cause changes in brain cells that may lead to tumor development.\n3. CT scans can cause inflammation in the brain, which can increase tumor risk.\n4. It is recommended that CT scans be used only when absolutely necessary.",
    "llama-7b_fact": [
      "Head CT scans may increase the risk of developing a brain tumor.",
      "Repeated exposure to radiation from CT scans can cause changes in brain cells that may lead to tumor development.",
      "CT scans can cause inflammation in the brain, which can increase tumor risk.",
      "It is recommended that CT scans be used only when absolutely necessary."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-7b_response": "Otx2 is associated with the embryonic stem cell pluripotency.",
    "llama-7b_fact_raw": "1. Otx2 is associated with pluripotency.\n2. The type of pluripotency associated with Otx2 is embryonic stem cell pluripotency.",
    "llama-7b_fact": [
      "Otx2 is associated with pluripotency.",
      "The type of pluripotency associated with Otx2 is embryonic stem cell pluripotency."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-7b_response": "Approximately 200 DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region.",
    "llama-7b_fact_raw": "1. There are approximately 200 DNaseI hypersensitive sites that mark the murine beta globin locus region.",
    "llama-7b_fact": [
      "There are approximately 200 DNaseI hypersensitive sites that mark the murine beta globin locus region."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN",
    "llama-7b_judge": [
      "unknown"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-7b_response": "There are several European influenza vaccines available, including Fluarix (GlaxoSmithKline), FluLaval (Sanofi Pasteur), Fluvirin (Novartis), and Fluzone (Sanofi Pasteur).",
    "llama-7b_fact_raw": "1. Fluarix is a European influenza vaccine produced by GlaxoSmithKline.\n2. FluLaval is a European influenza vaccine produced by Sanofi Pasteur.\n3. Fluvirin is a European influenza vaccine produced by Novartis.\n4. Fluzone is a European influenza vaccine produced by Sanofi Pasteur.",
    "llama-7b_fact": [
      "Fluarix is a European influenza vaccine produced by GlaxoSmithKline.",
      "FluLaval is a European influenza vaccine produced by Sanofi Pasteur.",
      "Fluvirin is a European influenza vaccine produced by Novartis.",
      "Fluzone is a European influenza vaccine produced by Sanofi Pasteur."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: FluLaval is an influenza vaccine produced by GlaxoSmithKline, not Sanofi Pasteur.\n3. FALSE [correction]: Fluvirin was previously produced by Novartis, but as of 2015, the Fluvirin brand is owned by Seqirus.\n4. FALSE [correction]: Fluzone is an influenza vaccine produced by Sanofi Pasteur, but it is not exclusive to Europe.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-7b_response": "Yes, the Paramyxovirus geneome segmented, negative-sense RNA.",
    "llama-7b_fact_raw": "1. The Paramyxovirus genome is segmented.\n2. The Paramyxovirus genome is negative-sense RNA.",
    "llama-7b_fact": [
      "The Paramyxovirus genome is segmented.",
      "The Paramyxovirus genome is negative-sense RNA."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Paramyxovirus genome is non-segmented.\n2. TRUE",
    "llama-7b_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-7b_response": "Roflumilast Cream is effective for treating chronic obstructive pulmonary disease (COPD).",
    "llama-7b_fact_raw": "1. Roflumilast Cream is used to treat chronic obstructive pulmonary disease (COPD).",
    "llama-7b_fact": [
      "Roflumilast Cream is used to treat chronic obstructive pulmonary disease (COPD)."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Roflumilast is a medication in pill form used to treat chronic obstructive pulmonary disease (COPD), not a cream.",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-7b_response": "Several tools have been developed for identifying and visualising ncRNA promoters. These include the Promoter Analysis Tool (PAT), the NcRNA Promoter Analysis Tool (N-PAT), the Non-Coding RNA Promoter Finder (NCRPF), the Non-Coding RNA Promoter Analysis Tool (NC-PAT), and the Non-Coding RNA Promoter Visualization Tool (NCRVT). All of these tools are designed to help researchers identify and visualise the promoters of non-coding RNAs.",
    "llama-7b_fact_raw": "1. The Promoter Analysis Tool (PAT) has been developed for identifying and visualising ncRNA promoters.\n2. The NcRNA Promoter Analysis Tool (N-PAT) is a tool developed for the same purpose.\n3. Another tool developed for identifying and visualising ncRNA promoters is the Non-Coding RNA Promoter Finder (NCRPF).\n4. The Non-Coding RNA Promoter Analysis Tool (NC-PAT) has been designed to help researchers with ncRNA promoters.\n5. The Non-Coding RNA Promoter Visualization Tool (NCRVT) is also available for visualizing ncRNA promoters.",
    "llama-7b_fact": [
      "The Promoter Analysis Tool (PAT) has been developed for identifying and visualising ncRNA promoters.",
      "The NcRNA Promoter Analysis Tool (N-PAT) is a tool developed for the same purpose.",
      "Another tool developed for identifying and visualising ncRNA promoters is the Non-Coding RNA Promoter Finder (NCRPF).",
      "The Non-Coding RNA Promoter Analysis Tool (NC-PAT) has been designed to help researchers with ncRNA promoters.",
      "The Non-Coding RNA Promoter Visualization Tool (NCRVT) is also available for visualizing ncRNA promoters."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-7b_response": "SWIM tool has identified and down-regulated several genes in glioblastoma, including PTEN, PDCD4, CDKN2A, and SMAD4.",
    "llama-7b_fact_raw": "1. The SWIM tool has identified the gene PTEN as down-regulated in glioblastoma.\n2. The SWIM tool has identified the gene PDCD4 as down-regulated in glioblastoma.\n3. The SWIM tool has identified the gene CDKN2A as down-regulated in glioblastoma.\n4. The SWIM tool has identified the gene SMAD4 as down-regulated in glioblastoma.",
    "llama-7b_fact": [
      "The SWIM tool has identified the gene PTEN as down-regulated in glioblastoma.",
      "The SWIM tool has identified the gene PDCD4 as down-regulated in glioblastoma.",
      "The SWIM tool has identified the gene CDKN2A as down-regulated in glioblastoma.",
      "The SWIM tool has identified the gene SMAD4 as down-regulated in glioblastoma."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout additional context or information about the SWIM tool's findings, it is not possible to determine the accuracy of these statements.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-7b_response": "Several R packages have been developed for studying TADs. These include: \n\n1. TADs: A package for the analysis of TADs.\n2. TADplot: A package for the visualization of TADs.\n3. TADview: A package for the interactive exploration of TADs.\n4. TADtrack: A package for the tracking of TADs.\n5. TADtrackR: A package for the tracking of TADs in a R environment.\n6. TADstack: A package for the analysis of TADstacks.\n7. TADstackR: A package for the analysis of TADstacks in a R environment.\n8. TADmatrix: A package for the analysis of TADmatrices.\n9. TADmatrixR: A package for the analysis of TADmatrices in a R environment.",
    "llama-7b_fact_raw": "1. TADs is an R package developed for the analysis of TADs.\n2. TADplot is an R package developed for the visualization of TADs.\n3. TADview is an R package developed for the interactive exploration of TADs.\n4. TADtrack is an R package developed for the tracking of TADs.\n5. TADtrackR is an R package developed for the tracking of TADs in a R environment.",
    "llama-7b_fact": [
      "TADs is an R package developed for the analysis of TADs.",
      "TADplot is an R package developed for the visualization of TADs.",
      "TADview is an R package developed for the interactive exploration of TADs.",
      "TADtrack is an R package developed for the tracking of TADs.",
      "TADtrackR is an R package developed for the tracking of TADs in a R environment."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\n[Note: Without context or confirmation from reputable sources, it's unclear if these R packages exist and what their specific functions are.]",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-7b_response": "The bioconductor tool that has been developed for accessing bacterial regulatory networks is the Bacterial Regulatory Networks (BRN) package. This package provides an interface for exploring and analyzing bacterial regulatory networks. It allows users to query, visualize, and analyze bacterial regulatory networks from a variety of species, including E. coli, Salmonella, and Staphylococcus aureus. The package also provides tools for predicting the effects of mutations on bacterial regulatory networks.",
    "llama-7b_fact_raw": "1. The Bacterial Regulatory Networks (BRN) package is a bioconductor tool developed for accessing bacterial regulatory networks.\n2. The BRN package provides an interface for exploring and analyzing bacterial regulatory networks.\n3. The BRN package includes tools for querying, visualizing, and analyzing regulatory networks from species such as E. coli, Salmonella, and Staphylococcus aureus.\n4. The BRN package offers tools for predicting the effects of mutations on bacterial regulatory networks.",
    "llama-7b_fact": [
      "The Bacterial Regulatory Networks (BRN) package is a bioconductor tool developed for accessing bacterial regulatory networks.",
      "The BRN package provides an interface for exploring and analyzing bacterial regulatory networks.",
      "The BRN package includes tools for querying, visualizing, and analyzing regulatory networks from species such as E. coli, Salmonella, and Staphylococcus aureus.",
      "The BRN package offers tools for predicting the effects of mutations on bacterial regulatory networks."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-7b_response": "The end products of the shikimate pathway are aromatic compounds such as aromatic amino acids, aromatic alcohols, and aromatic acids. These compounds are important building blocks for the synthesis of proteins, lipids, and other molecules in plants and some bacteria.",
    "llama-7b_fact_raw": "1. The shikimate pathway produces aromatic compounds.\n2. Aromatic amino acids, aromatic alcohols, and aromatic acids are end products of the shikimate pathway.\n3. These aromatic compounds are used to synthesize proteins, lipids, and other molecules in plants and some bacteria.",
    "llama-7b_fact": [
      "The shikimate pathway produces aromatic compounds.",
      "Aromatic amino acids, aromatic alcohols, and aromatic acids are end products of the shikimate pathway.",
      "These aromatic compounds are used to synthesize proteins, lipids, and other molecules in plants and some bacteria."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-7b_response": "Yes, cabergoline is used for the treatment of Nelson's syndrome, which is a rare condition that occurs when a patient with a pituitary adenoma develops a prolactin-secreting tumor. Cabergoline is a dopamine agonist that is used to reduce prolactin levels and decrease the size of the tumor.",
    "llama-7b_fact_raw": "1. Cabergoline is used for the treatment of Nelson's syndrome.\n2. Nelson's syndrome is a rare condition that occurs when a patient with a pituitary adenoma develops a prolactin-secreting tumor.\n3. Cabergoline is a dopamine agonist.\n4. Cabergoline is used to reduce prolactin levels.\n5. Cabergoline can decrease the size of the tumor.",
    "llama-7b_fact": [
      "Cabergoline is used for the treatment of Nelson's syndrome.",
      "Nelson's syndrome is a rare condition that occurs when a patient with a pituitary adenoma develops a prolactin-secreting tumor.",
      "Cabergoline is a dopamine agonist.",
      "Cabergoline is used to reduce prolactin levels.",
      "Cabergoline can decrease the size of the tumor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Cabergoline is used for the treatment of hyperprolactinemia and Parkinson's disease, not Nelson's syndrome.\n2. FALSE [correction]: Nelson's syndrome is a rare condition that occurs after the surgical removal of a pituitary adenoma when ACTH levels rise and cause skin darkening and tumor growth.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-7b_response": "The main manifestation of Liebenberg syndrome is a painful, red, and swollen joint, usually the knee. Other symptoms may include fever, stiffness, and limited mobility.",
    "llama-7b_fact_raw": "1. Liebenberg syndrome's main manifestation is a painful, red, and swollen joint.\n2. The knee is usually the joint affected by Liebenberg syndrome.\n3. Fever, stiffness, and limited mobility are other symptoms of Liebenberg syndrome.",
    "llama-7b_fact": [
      "Liebenberg syndrome's main manifestation is a painful, red, and swollen joint.",
      "The knee is usually the joint affected by Liebenberg syndrome.",
      "Fever, stiffness, and limited mobility are other symptoms of Liebenberg syndrome."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-7b_response": "Orally bioavailable MPS1 kinase inhibitors include sorafenib, pazopanib, and sunitinib.",
    "llama-7b_fact_raw": "1. Sorafenib is an orally bioavailable MPS1 kinase inhibitor.\n2. Pazopanib is an orally bioavailable MPS1 kinase inhibitor.\n3. Sunitinib is an orally bioavailable MPS1 kinase inhibitor.",
    "llama-7b_fact": [
      "Sorafenib is an orally bioavailable MPS1 kinase inhibitor.",
      "Pazopanib is an orally bioavailable MPS1 kinase inhibitor.",
      "Sunitinib is an orally bioavailable MPS1 kinase inhibitor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Sorafenib is an orally bioavailable RAF kinase inhibitor.\n2. FALSE [correction]: Pazopanib is an orally bioavailable tyrosine kinase inhibitor that targets multiple kinases, but not specifically MPS1.\n3. FALSE [correction]: Sunitinib is an orally bioavailable tyrosine kinase inhibitor that targets multiple kinases, including PDGF receptors, VEGF receptors, and others, but not specifically MPS1.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-7b_response": "Golimumab has not been tested specifically for the treatment of diabetes. However, it has been studied in clinical trials for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis, and the safety and efficacy of golimumab in patients with diabetes has not been established.",
    "llama-7b_fact_raw": "1. Golimumab has not been specifically tested for the treatment of diabetes.\n2. Golimumab has been studied in clinical trials for rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.\n3. The safety and efficacy of golimumab in patients with diabetes has not been established.",
    "llama-7b_fact": [
      "Golimumab has not been specifically tested for the treatment of diabetes.",
      "Golimumab has been studied in clinical trials for rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.",
      "The safety and efficacy of golimumab in patients with diabetes has not been established."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-7b_response": "No, progeria is not caused by an autosomal recessive gene. Progeria is a rare genetic disorder that is caused by a mutation in the lamin A gene on the short arm of chromosome 18. This mutation is dominant, meaning that one copy of the mutated gene is sufficient to cause the disorder.",
    "llama-7b_fact_raw": "1. Progeria is not caused by an autosomal recessive gene.\n2. Progeria is caused by a mutation in the lamin A gene.\n3. The lamin A gene mutation that causes progeria is located on the short arm of chromosome 18.\n4. The mutation responsible for progeria is dominant, meaning one copy of the mutated gene can cause the disorder.",
    "llama-7b_fact": [
      "Progeria is not caused by an autosomal recessive gene.",
      "Progeria is caused by a mutation in the lamin A gene.",
      "The lamin A gene mutation that causes progeria is located on the short arm of chromosome 18.",
      "The mutation responsible for progeria is dominant, meaning one copy of the mutated gene can cause the disorder."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The lamin A gene mutation that causes progeria is located on chromosome 1.\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-7b_response": "Common variants at 12q14 and 12q24 are associated with an increased risk of developing schizophrenia and bipolar disorder, respectively.",
    "llama-7b_fact_raw": "1. Common variants at 12q14 are associated with an increased risk of developing schizophrenia.\n2. Common variants at 12q24 are associated with an increased risk of developing bipolar disorder.",
    "llama-7b_fact": [
      "Common variants at 12q14 are associated with an increased risk of developing schizophrenia.",
      "Common variants at 12q24 are associated with an increased risk of developing bipolar disorder."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-7b_response": "The ligands of the Roundabout (Robo) receptors are Slit, Robo1, Robo2, and Robo3.",
    "llama-7b_fact_raw": "1. Slit is a ligand of Roundabout (Robo) receptors.\n2. Robo1 is a ligand of Roundabout (Robo) receptors.\n3. Robo2 is a ligand of Roundabout (Robo) receptors.\n4. Robo3 is a ligand of Roundabout (Robo) receptors.",
    "llama-7b_fact": [
      "Slit is a ligand of Roundabout (Robo) receptors.",
      "Robo1 is a ligand of Roundabout (Robo) receptors.",
      "Robo2 is a ligand of Roundabout (Robo) receptors.",
      "Robo3 is a ligand of Roundabout (Robo) receptors."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Robo1 is not a ligand but a type of Roundabout (Robo) receptor.\n3. FALSE [correction]: Robo2 is not a ligand but another type of Roundabout (Robo) receptor.\n4. FALSE [correction]: Robo3 is not a ligand but yet another type of Roundabout (Robo) receptor.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-7b_response": "Yes, TFII-I plays an important role in megakaryopoiesis. TFII-I is a transcription factor that is essential for the formation of megakaryocytes, a type of blood cell that produces platelets. TFII-I binds to the promoter region of genes involved in the formation of megakaryocytes and activates their transcription. Without TFII-I, megakaryopoiesis cannot occur.",
    "llama-7b_fact_raw": "1. TFII-I is a transcription factor.\n2. TFII-I is essential for the formation of megakaryocytes.\n3. Megakaryocytes are a type of blood cell that produces platelets.\n4. TFII-I activates the transcription of genes involved in the formation of megakaryocytes by binding to their promoter region.\n5. Without TFII-I, megakaryopoiesis cannot occur.",
    "llama-7b_fact": [
      "TFII-I is a transcription factor.",
      "TFII-I is essential for the formation of megakaryocytes.",
      "Megakaryocytes are a type of blood cell that produces platelets.",
      "TFII-I activates the transcription of genes involved in the formation of megakaryocytes by binding to their promoter region.",
      "Without TFII-I, megakaryopoiesis cannot occur."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: TFII-I is not essential for the formation of megakaryocytes, but it does play a role in their development.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Megakaryopoiesis can still occur without TFII-I, but the process may be less efficient or effective.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-7b_response": "Yes, atenolol is metabolized by the cytochrome P450 enzyme CYP2D6. CYP2D6 is responsible for the majority of the metabolism of atenolol, with additional metabolism by other enzymes, including CYP1A2, CYP3A4, and CYP4A11. CYP2D6 is an important enzyme in the metabolism of many drugs, including other beta-blockers, and genetic variations in the CYP2D6 gene can affect the metabolism of atenolol and other drugs.",
    "llama-7b_fact_raw": "1. Atenolol is metabolized by the cytochrome P450 enzyme CYP2D6.\n2. CYP2D6 is responsible for the majority of the metabolism of atenolol.\n3. Other enzymes involved in atenolol metabolism include CYP1A2, CYP3A4, and CYP4A11.\n4. CYP2D6 is an important enzyme in the metabolism of many drugs, including other beta-blockers.\n5. Genetic variations in the CYP2D6 gene can affect the metabolism of atenolol and other drugs.",
    "llama-7b_fact": [
      "Atenolol is metabolized by the cytochrome P450 enzyme CYP2D6.",
      "CYP2D6 is responsible for the majority of the metabolism of atenolol.",
      "Other enzymes involved in atenolol metabolism include CYP1A2, CYP3A4, and CYP4A11.",
      "CYP2D6 is an important enzyme in the metabolism of many drugs, including other beta-blockers.",
      "Genetic variations in the CYP2D6 gene can affect the metabolism of atenolol and other drugs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Atenolol is not primarily metabolized by cytochrome P450 enzymes such as CYP2D6; it is mainly excreted unchanged in the urine.\n2. FALSE [correction]: Since CYP2D6 is not the main enzyme responsible for atenolol metabolism, it does not account for the majority of its metabolism.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-7b_response": "There are several versions of ExpansionHunter available, including the free version, the premium version, the pro version, and the ultimate version. Each version offers different features and benefits, such as increased storage capacity, more powerful tools, and access to exclusive content.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-7b_response": "Adamts18 is a metalloprotease that is involved in the regulation of hormone receptor signaling. It has been shown to play a role in the activation of estrogen and androgen receptors, as well as the inactivation of progesterone receptors. Adamts18 has also been found to be involved in the regulation of cell proliferation, migration, and invasion in breast cancer cells.",
    "llama-7b_fact_raw": "1. Adamts18 is a metalloprotease.\n2. Adamts18 is involved in the regulation of hormone receptor signaling.\n3. Adamts18 plays a role in the activation of estrogen and androgen receptors.\n4. Adamts18 is involved in the inactivation of progesterone receptors.\n5. Adamts18 has a role in the regulation of cell proliferation, migration, and invasion in breast cancer cells.",
    "llama-7b_fact": [
      "Adamts18 is a metalloprotease.",
      "Adamts18 is involved in the regulation of hormone receptor signaling.",
      "Adamts18 plays a role in the activation of estrogen and androgen receptors.",
      "Adamts18 is involved in the inactivation of progesterone receptors.",
      "Adamts18 has a role in the regulation of cell proliferation, migration, and invasion in breast cancer cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Adamts18 is not directly involved in the activation of estrogen and androgen receptors; its role is related to the regulation of hormone receptor signaling pathways.\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-7b_response": "Thiazovivin is a chemotherapy drug that works by inhibiting the enzyme thiazole dioxygenase, which is involved in the biosynthesis of folate. By inhibiting this enzyme, thiazovivin prevents the production of tetrahydrofolate, an essential component of the folate pathway. This disruption of the folate pathway leads to cell death, which is the primary mode of action of Thiazovivin.",
    "llama-7b_fact_raw": "1. Thiazovivin is a chemotherapy drug.\n2. Thiazovivin inhibits the enzyme thiazole dioxygenase.\n3. Thiazole dioxygenase is involved in the biosynthesis of folate.\n4. Inhibition of thiazole dioxygenase by Thiazovivin prevents the production of tetrahydrofolate.\n5. The primary mode of action of Thiazovivin is to lead to cell death by disrupting the folate pathway.",
    "llama-7b_fact": [
      "Thiazovivin is a chemotherapy drug.",
      "Thiazovivin inhibits the enzyme thiazole dioxygenase.",
      "Thiazole dioxygenase is involved in the biosynthesis of folate.",
      "Inhibition of thiazole dioxygenase by Thiazovivin prevents the production of tetrahydrofolate.",
      "The primary mode of action of Thiazovivin is to lead to cell death by disrupting the folate pathway."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Thiazovivin is not a chemotherapy drug; it is a small molecule inhibitor used in stem cell research.\n2. FALSE [correction]: Thiazovivin inhibits Rho-associated kinase (ROCK), not thiazole dioxygenase.\n3. TRUE\n4. FALSE [correction]: Inhibition of thiazole dioxygenase would prevent the production of tetrahydrofolate, but Thiazovivin does not inhibit this enzyme.\n5. FALSE [correction]: The primary mode of action of Thiazovivin is to enhance the survival and cloning efficiency of human stem cells by inhibiting ROCK, not by disrupting the folate pathway.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  }
]